George Perry | Academic Influence

George Perry 's AcademicInfluence.com Rankings

George Perry

Biology

#1242

World Rank

#2110

Historical Rank

#638

USA Rank

Neuroscience

#192

World Rank

#204

Historical Rank

#81

USA Rank

biology Degrees

Download Badge

Biology

George Perry 's Degrees

Doctorate Medicine Case Western Reserve University

Why Is George Perry Influential?

(Suggest an Edit or Addition)

According to Wikipedia, George Perry is a professor of biology and chemistry at the University of Texas at San Antonio and the former dean of the College of Sciences. Perry is recognized in the field of Alzheimer's disease research, particularly for his work on oxidative stress.

(See a Problem?)

George Perry 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (2008) (2360)
Oxidative Damage Is the Earliest Event in Alzheimer Disease (2001) (1811)
Mitochondrial abnormalities in Alzheimer disease (2000) (1275)
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. (1997) (1255)
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease (1997) (1246)
Oxidative stress in Alzheimer's disease. (2000) (1122)
Natural products in drug discovery: advances and opportunities (2021) (1082)
4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease (1997) (990)
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease (2009) (981)
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. (2014) (940)
Oxidative damage in Alzheimer's (1996) (927)
Oxidative stress and neurotoxicity. (2008) (740)
Advanced Maillard reaction end products are associated with Alzheimer disease pathology (1994) (730)
RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease (1999) (721)
Chemistry and biochemistry of oxidative stress in neurodegenerative disease. (2001) (623)
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. (1999) (614)
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. (2010) (610)
Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. (1987) (596)
Involvement of Oxidative Stress in Alzheimer Disease (2006) (556)
Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress (1998) (553)
Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. (2003) (525)
In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease (2000) (512)
Radical AGEing in Alzheimer's disease (1995) (475)
Oxidative stress in Alzheimer disease: A possibility for prevention (2010) (446)
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. (1994) (437)
Alzheimer's disease: the two-hit hypothesis (2004) (417)
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease (2012) (416)
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide (1995) (414)
Alzheimer Disease and Oxidative Stress (2002) (414)
Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease (2001) (409)
Oxidative stress signalling in Alzheimer's disease (2004) (393)
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. (2012) (380)
Oxidative Stress Increases Expression and Activity of BACE in NT2 Neurons (2002) (368)
Microbes and Alzheimer's Disease. (2016) (367)
Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* (2000) (361)
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances (2020) (361)
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. (2010) (350)
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. (1998) (348)
The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease (2002) (345)
Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease (2000) (345)
Role of mitochondrial dysfunction in Alzheimer's disease (2002) (344)
Redox-active iron mediates amyloid-β toxicity (2001) (340)
Oxidative stress signaling in Alzheimer's disease. (2008) (335)
β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways (2005) (324)
Causes of oxidative stress in Alzheimer disease (2007) (323)
Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. (2004) (320)
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (2003) (316)
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease (1996) (314)
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis (2001) (302)
Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? (2002) (302)
Oxidative Stress and Neurodegeneration (2005) (300)
Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome (2000) (294)
Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. (2003) (290)
Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts (1998) (288)
Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein (2007) (283)
Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. (1999) (282)
Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system (1993) (281)
Systemic Increase of Oxidative Nucleic Acid Damage in Parkinson's Disease and Multiple System Atrophy (2002) (279)
Microglial activation and amyloid‐β clearance induced by exogenous heat‐shock proteins (2002) (279)
How important is oxidative damage? Lessons from Alzheimer's disease. (2000) (278)
Activation of NADPH oxidase in Alzheimer's disease brains. (2000) (277)
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis (2013) (275)
Alzheimer disease, the two-hit hypothesis: an update. (2007) (274)
Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron* (2005) (270)
Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease (1998) (270)
Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β (2003) (266)
Role of metal dyshomeostasis in Alzheimer's disease. (2011) (265)
The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease (2009) (257)
Mitochondria: a therapeutic target in neurodegeneration. (2010) (253)
Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. (1991) (252)
Abnormal mitochondrial dynamics and neurodegenerative diseases. (2010) (252)
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease (1998) (246)
Oxidative stress in diabetes and Alzheimer's disease. (2009) (243)
Tau phosphorylation in Alzheimer's disease: pathogen or protector? (2005) (232)
Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine (1998) (230)
Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease (1995) (227)
Sequestration of iron by Lewy bodies in Parkinson’s disease (2000) (221)
Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. (1985) (221)
Redox metals and neurodegenerative disease. (1999) (219)
Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease (1995) (214)
Oxidative Stress and Redox‐Active Iron in Alzheimer's Disease (2004) (207)
Variably protease‐sensitive prionopathy: A new sporadic disease of the prion protein (2010) (207)
Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study (2018) (204)
Phosphorylation of Neurofilaments Is Altered in Amyotrophic Lateral Sclerosis (1988) (204)
Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults. (2012) (204)
Phosphorylation of tau protein at sites Ser396–404 is one of the earliest events in Alzheimer's disease and Down syndrome (2014) (204)
Copernicus revisited: amyloid beta in Alzheimer’s disease (2001) (202)
Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation (2000) (201)
The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction (1999) (201)
In Alzheimer's Disease, Heme Oxygenase Is Coincident with Alz50, an Epitope of τ Induced by 4‐Hydroxy‐2‐Nonenal Modification (2000) (200)
Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease? (2011) (198)
Nucleic acid oxidation in Alzheimer disease. (2008) (196)
Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease (1993) (195)
Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. (2012) (195)
Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. (1988) (195)
The up‐regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α (2009) (193)
Overexpression of Heme Oxygenase in Neuronal Cells, the Possible Interaction with Tau* (2000) (190)
Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. (2008) (187)
Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease. (1998) (186)
Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine (2001) (186)
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. (1990) (185)
The Amyloid-β Pathway in Alzheimer’s Disease (2021) (185)
Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease (2007) (184)
Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid‐β as Protective Adaptations to Alzheimer Disease (2004) (183)
Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein (2001) (182)
Vascular oxidative stress in Alzheimer disease (2007) (180)
Tau – an inhibitor of deacetylase HDAC6 function (2009) (179)
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. (2006) (176)
Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain (2002) (176)
From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). (2008) (175)
The Role of Oxidative Stress in the Pathophysiology of Cerebrovascular Lesions in Alzheimer's Disease (2002) (173)
Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. (2006) (173)
Abnormal localization of iron regulatory protein in Alzheimer's disease (1998) (172)
Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. (2007) (171)
Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. (2007) (168)
Alzheimer Disease Pathology As a Host Response (2008) (168)
Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions (1990) (165)
Neurofilament proteins in neurodegenerative diseases (2004) (164)
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans (2002) (163)
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance (2006) (163)
Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects (2019) (162)
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. (2000) (160)
Chondroitin Sulfate Proteoglycans Are Associated with the Lesions of Alzheimer's Disease (1993) (160)
Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease (1991) (159)
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? (2003) (158)
Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid-β Precursor Protein and Amyloid-β Deposition* (2004) (158)
Meta-analysis of Telomere Length in Alzheimer's Disease. (2016) (158)
Oxidative Damage to RNA in Aging and Neurodegenerative Disorders (2012) (157)
Abortive apoptosis in Alzheimer's disease (2001) (156)
Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. (2007) (155)
Alzheimer disease and the role of free radicals in the pathogenesis of the disease. (2008) (154)
Insulin is a two-edged knife on the brain. (2009) (154)
Metal ions and oxidative protein modification in neurological disease. (2005) (153)
Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. (1993) (153)
4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. (2005) (153)
Advanced Maillard Reaction End Products, Free Radicals, and Protein Oxidation in Alzheimer's Disease a (1994) (153)
Autophagocytosis of mitochondria is prominent in Alzheimer disease (2007) (152)
RNA oxidation in Alzheimer disease and related neurodegenerative disorders (2009) (151)
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton (1991) (151)
Redox-active iron mediates amyloid-beta toxicity. (2001) (151)
LIPID PEROXIDATION AND PROTEIN OXIDATION IN ALZHEIMER'S DISEASE BRAIN: POTENTIAL CAUSES AND CONSEQUENCES INVOLVING AMYLOID -PEPTIDE-ASSOCIATED FREE RADICAL OXIDATIVE STRESS (2002) (149)
Antioxidant therapy in Alzheimer's disease: theory and practice. (2008) (149)
β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth (1993) (148)
The glucose transporter of the human brain and blood‐brain barrier (1988) (147)
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation (2012) (147)
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases (2019) (146)
Activation of MKK6, an upstream activator of p38, in Alzheimer's disease (2001) (145)
Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins (2002) (144)
The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. (1990) (144)
Molecular toxicity of aluminium in relation to neurodegeneration. (2008) (143)
Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses (2007) (142)
Increased Autophagic Degradation of Mitochondria in Alzheimer Disease (2007) (142)
Barrier properties of testis microvessels. (1993) (141)
Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. (2007) (141)
Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. (2000) (141)
A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. (2010) (140)
Oxidative imbalance in alzheimer’s disease (2007) (140)
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells (2010) (140)
The Vascular Impairment of Cognition Classification Consensus Study (2017) (140)
Nanoparticle and other metal chelation therapeutics in Alzheimer disease. (2005) (139)
Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. (2013) (138)
Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. (2002) (138)
Iron: A Pathological Mediator of Alzheimer Disease? (2002) (138)
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease (2009) (136)
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease (2004) (135)
Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. (2008) (135)
Filaments of Lewy bodies contain insoluble cytoskeletal elements. (1992) (135)
Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease (2009) (135)
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. (2009) (133)
Acute thymic involution in fetuses and neonates with chorioamnionitis. (2000) (133)
Hibernation, a model of neuroprotection. (2001) (133)
Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer's disease. (2016) (133)
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes (2008) (132)
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders (2019) (132)
Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. (2005) (131)
Paramyosin and actin in schistosomal teguments (1988) (131)
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells (2003) (131)
Lewy Bodies Contain Epitopes Both Shared and Distinct from Alzheimer Neurofibrillary Tangles (1988) (130)
Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds (2015) (130)
Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease (2008) (130)
Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. (2000) (129)
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic (2006) (128)
Cl−-ATPase and Na+/K+-ATPase activities in Alzheimer's disease brains (1998) (127)
Pathomechanisms of TDP‐43 in neurodegeneration (2018) (127)
High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal* (2002) (127)
The role of metals in neurodegenerative diseases. (2000) (126)
Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats (2008) (126)
Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. (1997) (126)
Vascular Oxidative Stress: Impact and Therapeutic Approaches (2018) (124)
Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease. (2004) (124)
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. (2005) (124)
Leptin: a novel therapeutic strategy for Alzheimer's disease. (2009) (124)
Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease (2013) (123)
Oxidative Damage to RNA in Neurodegenerative Diseases (2006) (123)
Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. (1999) (123)
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology (2002) (123)
Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. (2003) (122)
Hirano Body Filaments Contain Actin and Actin‐Associated Proteins (1987) (121)
Oxidative damage in Alzheimer’s disease: the metabolic dimension (2000) (119)
Free radical damage, iron, and Alzheimer's disease (1995) (119)
Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease (2004) (118)
Faculty Opinions recommendation of Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. (2011) (118)
Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. (2006) (118)
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. (2010) (118)
Early glycoxidation damage in brains from Down's syndrome. (1998) (117)
Antioxidant approaches for the treatment of Alzheimer’s disease (2010) (117)
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease (2009) (117)
Mitochondrial failures in Alzheimer's disease (2004) (117)
Neuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome (1999) (116)
Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease. (1992) (115)
Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons (2010) (115)
Current approaches in the treatment of Alzheimer's disease. (2008) (114)
Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4‐hydroxy‐2‐nonenal (2000) (114)
Deconstructing Mitochondrial Dysfunction in Alzheimer Disease (2013) (113)
Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. (2012) (112)
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease (2009) (111)
DLP1‐dependent mitochondrial fragmentation mediates 1‐methyl‐4‐phenylpyridinium toxicity in neurons: implications for Parkinson’s disease (2011) (111)
Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. (1999) (111)
PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease. (2016) (109)
MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents. (2017) (109)
Neuronutrition and Alzheimer's disease. (2010) (108)
Oxidative stress mechanisms and potential therapeutics in Alzheimer disease (2005) (107)
Carnosine: a versatile antioxidant and antiglycating agent. (2005) (106)
Hydroxynonenal, toxic carbonyls, and Alzheimer disease. (2003) (106)
Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance (2014) (106)
Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. (2002) (105)
High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer’s disease (2016) (105)
Increases in luteinizing hormone are associated with declines in cognitive performance (2007) (104)
The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons (2012) (104)
Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model (2017) (103)
Glucose transporters are abundant in cells with "occluding" junctions at the blood-eye barriers. (1990) (102)
A suicide note from Alzheimer disease neurons? (1998) (102)
Oxidative Stress, Antioxidants, and Alzheimer Disease (2000) (101)
Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology. (2017) (101)
Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. (2004) (100)
Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease (2003) (100)
The neuroprotective activities of melatonin against the Alzheimer β‐protein are not mediated by melatonin membrane receptors (2002) (99)
Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress. (2012) (98)
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease (2019) (98)
Amyloid beta: the alternate hypothesis. (2006) (98)
Signal transduction cascades associated with oxidative stress in Alzheimer's disease. (2007) (98)
Beta-secretase: structure, function, and evolution. (2008) (98)
Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. (1988) (97)
Atherosclerotic Lesions and Mitochondria DNA Deletions in Brain Microvessels as a Central Target for the Development of Human AD and AD‐Like Pathology in Aged Transgenic Mice (2002) (97)
Mechanisms by which metals promote events connected to neurodegenerative diseases (2001) (96)
Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease. (2013) (96)
Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease (1996) (95)
The Amyloid Precursor Protein in Ischemic Brain Injury and Chronic Hypoperfusion a (1993) (94)
The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders (2002) (94)
Hirano bodies contain tau protein (1987) (94)
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. (1991) (94)
Amyloid‐β‐induced toxicity of primary neurons is dependent upon differentiation‐associated increases in tau and cyclin‐dependent kinase 5 expression (2003) (93)
Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease (2007) (93)
Increased p27, an essential component of cell cycle control, in Alzheimer's disease (2003) (93)
Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease (2010) (93)
Vascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆ (2000) (93)
Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease (2010) (92)
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice (2003) (92)
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease (2004) (91)
Selective presence of ubiquitin in intracellular inclusions. (1989) (91)
NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-beta peptide. (2010) (91)
Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders (1991) (91)
Nanoparticle and iron chelators as a potential novel Alzheimer therapy. (2010) (91)
The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. (2009) (90)
A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease. (2009) (90)
Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson’s Disease (2013) (90)
Lipoperoxidation Is Selectively Involved in Progressive Supranuclear Palsy (2000) (90)
Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass (2014) (89)
Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. (2004) (89)
Synaptic dysfunction and oxidative stress in Alzheimer’s disease: Emerging mechanisms (2006) (87)
Oxidative RNA damage and neurodegeneration. (2007) (86)
Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease (1995) (86)
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. (2002) (86)
Microglia are associated with the extracellular neurofibrillary tangles of alzheimer disease (1991) (86)
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease (2002) (85)
Apoptosis in Alzheimer disease: a mathematical improbability. (2006) (85)
Phosphorylated tau: toxic, protective, or none of the above. (2008) (85)
Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. (2001) (84)
Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease. (1999) (83)
Transgenic Mouse Models of Alzheimer’s Disease: Behavioral Testing and Considerations (2009) (83)
Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? (1999) (83)
Oxidative damage in the olfactory system in Alzheimer's disease (2003) (83)
Apoptosis and Alzheimer's Disease (1998) (83)
Amyloid-β junkies (2000) (82)
Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies (2002) (82)
Oxidative stress in Alzheimers disease (2000) (82)
Parallels Between Major Depressive Disorder and Alzheimer’s Disease: Role of Oxidative Stress and Genetic Vulnerability (2014) (82)
The complexities of the pathology-pathogenesis relationship in Alzheimer disease. (2014) (82)
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients (2004) (82)
TDP-43/FUS in motor neuron disease: Complexity and challenges (2016) (81)
Oxidative Damage to Nucleic Acids in Human Prion Disease (2002) (81)
Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. (2002) (81)
Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide. (2011) (81)
Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease (2010) (81)
Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease (2017) (80)
Evidence for oxidative stress in Pick disease and corticobasal degeneration (1995) (80)
c‐Jun phosphorylation in Alzheimer disease (2007) (80)
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease (2009) (79)
Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein (1989) (78)
Prion Protein Glycosylation Is Sensitive to Redox Change* (1999) (78)
Physiological regulation of tau phosphorylation during hibernation (2008) (77)
Oxidative damage in Alzheimer''s disease (1996) (77)
Apoptosis and Alzheimer's disease [5] (1998) (77)
Involvement of maillard reactions in Alzheimer disease (2009) (75)
The role of iron as a mediator of oxidative stress in Alzheimer disease (2012) (75)
Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. (2008) (75)
Role of high mobility group protein-1 (HMG1) in amyloid-β homeostasis (2003) (75)
Posttranslational modifications of α-tubulin in alzheimer disease (2015) (74)
Precision pharmacology for Alzheimer's disease. (2018) (74)
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease (2009) (73)
Filaments of Pick's bodies contain altered cytoskeletal elements. (1987) (73)
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy (1988) (73)
Biomarkers in Alzheimer's disease: past, present and future. (2010) (73)
Overexpression of GRK2 in alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions (2006) (73)
Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases (1994) (73)
Telomeres and telomerase in Alzheimer’s disease: Epiphenomena or a new focus for therapeutic strategy? (2006) (73)
Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease. (2014) (73)
Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide (2007) (72)
Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease. (2015) (72)
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. (2004) (72)
LRRK2 protein is a component of lewy bodies (2006) (71)
Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? (2002) (71)
Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response. (2002) (71)
Early AGEing and Alzheimer's (1995) (71)
Role of the antioxidant ascorbate in hibernation and warming from hibernation. (2002) (70)
AMYLOID PRECURSOR PROTEIN IN SENILE PLAQUES OF ALZHEIMER DISEASE (1988) (70)
Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. (2007) (69)
Immunochemical Properties of Ubiquitin Conjugates in the Paired Helical Filaments of Alzheimer Disease (1989) (69)
Mitochondrial Dynamics in Alzheimer’s Disease (2010) (69)
Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints (2018) (69)
Quantification of trace elements in normal human brain by inductively coupled plasma atomic emission spectrometry (1997) (69)
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia (2009) (68)
Induction of HO-1 and NOS in Doppel-Expressing Mice Devoid of PrP: Implications for Doppel Function (2001) (68)
Cerebrovascular muscle atrophy is a feature of Alzheimer's disease (1998) (67)
Oxidative genome damage and its repair in neurodegenerative diseases: function of transition metals as a double-edged sword. (2011) (67)
Neuronal binucleation in Alzheimer disease hippocampus (2008) (67)
Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure (1992) (67)
Accelerated α-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells (2004) (67)
Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. (2003) (67)
DNA induces folding in alpha-synuclein: understanding the mechanism using chaperone property of osmolytes. (2007) (67)
Prevention and treatment of Alzheimer disease and aging: antioxidants. (2007) (67)
Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau (2006) (66)
Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks. (2016) (66)
Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. (2007) (66)
Arson: Tracking the Culprit in Alzheimer's Disease (2000) (66)
Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis (2010) (66)
Immunocytochemical properties of Alzheimer straight filaments (1987) (65)
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease (2008) (65)
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease (2005) (65)
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. (1992) (65)
Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases. (2012) (65)
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. (1995) (65)
Neurofilamentopathy in Neurodegenerative Diseases (2011) (65)
The impairment of insulin signaling in Alzheimer's disease (2012) (65)
Oxidative posttranslational modifications in Alzheimer disease (1996) (64)
Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease. (2007) (63)
Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease (2008) (62)
The amyloid cascade and Alzheimer’s disease therapeutics: theory versus observation (2019) (62)
The Autistic Phenotype Exhibits a Remarkably Localized Modification of Brain Protein by Products of Free Radical-Induced Lipid Oxidation (2008) (62)
Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway? (2006) (62)
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP‐1‐associated regulator of cyclin B, in Alzheimer's disease (2004) (62)
Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions. (1983) (62)
Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex (2018) (61)
Redox metals and oxidative abnormalities in human prion diseases (2005) (61)
JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease (2003) (61)
Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta‐analysis in human pathological specimens (2018) (61)
Causes and consequences of oxidative stress in Alzheimer's disease. (2002) (60)
Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease (2007) (60)
LRRK2 in Parkinson's disease and dementia with Lewy bodies (2006) (60)
Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains (2004) (60)
Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. (1991) (59)
Derivation and characterization of glycoinositol-phospholipid anchor-defective human K562 cell clones. (1992) (59)
BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease (2007) (59)
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases (2013) (59)
Nuclear and mitochondrial DNA oxidation in Alzheimer's disease (2012) (58)
Distribution, levels, and activation of MEK1 in Alzheimer's disease (2003) (58)
Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesis (2004) (57)
Quantitative solubilization and analysis of insoluble paired helical filaments from alzheimer disease (1996) (57)
Neuroprotective effect of cocoa flavonids on in vitro oxidative stress (2009) (57)
Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease. (2010) (57)
A Metabolic Basis for Alzheimer Disease (2003) (57)
Homocysteine and Alzheimer's disease: a modifiable risk? (2004) (57)
The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease (1989) (57)
Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease. (1998) (57)
Ranking Predatory Journals: Solve the Problem Instead of Removing It! (2016) (57)
The Alzheimer Precision Medicine Initiative. (2019) (56)
Abnormal tau‐reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease (1991) (56)
BARHL1 Is Downregulated in Alzheimer’s Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways (2017) (56)
Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress (1995) (56)
Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer’s disease (2004) (56)
Mitochondrial Preconditioning: A Potential Neuroprotective Strategy (2010) (55)
Signaling effect of amyloid-β42 on the processing of AβPP (2010) (55)
Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities (2016) (55)
Faculty Opinions recommendation of The prion protein as a receptor for amyloid-beta. (2010) (55)
Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease. (2019) (55)
The role of metabotropic glutamate receptors in Alzheimer's disease. (2004) (54)
Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential. (2014) (54)
Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease. (1992) (54)
Levuglandin E2-protein adducts in human plasma and vasculature. (1997) (54)
Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy (2012) (54)
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition (1989) (53)
Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges (2018) (53)
Perspectives on the Amyloid-β Cascade Hypothesis (2004) (53)
Amyloid‐β in Alzheimer's disease: the horse or the cart? Pathogenic or protective? (2005) (53)
CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains. (1998) (53)
Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology (2007) (52)
APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology (1996) (52)
Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. (2002) (52)
Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer’s disease (2017) (52)
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy. (2019) (52)
Miro1 deficiency in amyotrophic lateral sclerosis (2015) (51)
Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease. (1993) (51)
Altered Glycosylation Pattern of Proteins in Alzheimer Disease (1998) (51)
Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out? (2003) (51)
Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain (2013) (51)
In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders. (1999) (51)
Predicting the failure of amyloid-β vaccine (2002) (50)
Redox active iron accumulation in aceruloplasminemia (2008) (50)
Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease (2001) (50)
Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie‐infected mice (2004) (50)
Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. (2003) (50)
Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosis (2008) (49)
Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply (2003) (49)
Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model (2018) (49)
Neuroprotective properties of Bcl‐w in Alzheimer disease (2004) (49)
α‐Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson's disease (2006) (49)
Telomere length in Parkinson's disease: A meta-analysis (2016) (49)
A Novel Origin for Granulovacuolar Degeneration in Aging and Alzheimer’s Disease: Parallels to Stress Granules (2011) (48)
Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease (1990) (48)
Decreased salivary lactoferrin levels are specific to Alzheimer's disease (2020) (48)
Reactive oxygen species (ROS) and their impact in neurodegenerative diseases: literature landscape analysis. (2020) (48)
Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage. (2003) (47)
Aberrant localization of importin α1 in hippocampal neurons in Alzheimer disease (2006) (47)
Amyloid P component and other acute-phase proteins associated with cerebellar Aβ-deposits in Alzheimer's disease (1993) (47)
Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. (2004) (47)
New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders (2012) (47)
Mitochondria: the missing link between preconditioning and neuroprotection. (2010) (47)
Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron (2010) (47)
Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis (2015) (46)
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model. (2015) (46)
Do β-Defensins and Other Antimicrobial Peptides Play a Role in Neuroimmune Function and Neurodegeneration? (2012) (46)
Preventive and therapeutic strategies in Alzheimer's disease: focus on oxidative stress, redox metals and ferroptosis. (2020) (46)
Influence of neuronal location on antigenic properties of neurofibrillary tangles (1988) (46)
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks. (2015) (45)
Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches (2009) (45)
Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease (1992) (45)
Compensatory responses induced by oxidative stress in Alzheimer disease. (2006) (45)
Amyloid-β: a (life) preserver for the brain (2002) (45)
The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features1 (2017) (45)
Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease. (1990) (45)
Polyphenols in Alzheimer’s Disease and in the Gut–Brain Axis (2020) (44)
Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. (1993) (44)
TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration (2019) (44)
Therapeutic opportunities in Alzheimer disease: one for all or all for one? (2005) (44)
Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease. (2005) (44)
The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau (2002) (44)
Fractal Analysis in Human Pathology (1999) (43)
Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders. (2017) (43)
Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis (2005) (43)
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers (2018) (43)
Amyloid-β peptide structure in aqueous solution varies with fragment size. (2011) (43)
Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. (2008) (43)
Protein disulfide isomerase in Alzheimer disease. (2000) (43)
Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma (2019) (43)
Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. (2005) (42)
Chronological primacy of oxidative stress in Alzheimer disease (2005) (42)
The amyloid precursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types (1988) (42)
Therapeutic options in Alzheimer’s disease (2006) (42)
Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. (2004) (42)
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. (2003) (42)
Novel therapeutics for Alzheimer's disease: an update. (2010) (42)
The Contribution of Luteinizing Hormone to Alzheimer Disease Pathogenesis (2007) (42)
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence (2021) (42)
Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. (2007) (41)
Chitin-like polysaccharides in Alzheimer's disease brains. (2005) (41)
Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease (2008) (41)
Impact of RTN3 Deficiency on Expression of BACE1 and Amyloid Deposition (2014) (41)
Malignant glioma progression and nitric oxide (2006) (41)
RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs (2020) (40)
Atherosclerosis and aging. A morphometric study on arterial lesions of elderly and very elderly necropsy subjects. (1988) (40)
Complexity Analysis of the Viking Labeled Release Experiments (2012) (40)
Erythrocyte, plasma, and serum antioxidant activities in untreated toxic multinodular goiter patients. (2001) (40)
Kidney vascular damage and cocaine. (1997) (40)
The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms. (2013) (40)
Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease. (2013) (40)
Alteration of neuritic cytoarchitecture in Alzheimer disease. (1989) (40)
Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases (1992) (40)
Brain and brawn (2006) (40)
Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease (2016) (40)
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy (2002) (39)
Structures and free energy landscapes of aqueous zinc(II)-bound amyloid-β(1–40) and zinc(II)-bound amyloid-β(1–42) with dynamics (2012) (39)
The Neuronal Cytoskeleton (1992) (39)
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? (2007) (39)
P38 Activation Mediates Amyloid-β Cytotoxicity (2005) (39)
Role of antioxidants and a nutrient rich diet in Alzheimer's disease (2020) (39)
Heme catabolism and heme oxygenase in neurodegenerative disease. (2004) (39)
Rimmed vacuoles of inclusion body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers (1993) (39)
Retinoic acid isomers protect hippocampal neurons from amyloid-β induced neurodegeneration (2009) (38)
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease (2019) (38)
Atherosclerotic lesions are associated with increased immunoreactivity for inducible nitric oxide synthase and endothelin-1 in thoracic aortic intimal cells of hyperlipidemic Watanabe rabbits. (2001) (38)
Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective. (2019) (38)
Abnormal vascular network complexity: a new phenotypic marker in hereditary non-polyposis colorectal cancer syndrome (2003) (38)
Chronic Effects of Mild Neurotrauma: Putting the Cart Before the Horse? (2015) (38)
Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers (2010) (38)
Is oxidative damage central to the pathogenesis of Alzheimer disease? (1998) (38)
Reactive oxygen: its sources and significance in Alzheimer disease. (2002) (38)
Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. (2007) (38)
Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles. (2018) (38)
Regulation of glycogen synthase kinase‐3β by products of lipid peroxidation in human neuroblastoma cells (2004) (37)
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. (1996) (37)
Getting the iron out: phlebotomy for Alzheimer's disease? (2009) (37)
Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer’s Disease (AD): A Meta-Analysis of CSF Markers (2018) (37)
Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis (2019) (37)
Steroidogenic Acute Regulatory Protein (StAR): Evidence of Gonadotropin-Induced Steroidogenesis in Alzheimer Disease (2006) (37)
Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease (2009) (37)
A Novel Endogenous Indole Protects Rodent Mitochondria and Extends Rotifer Lifespan (2010) (37)
Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies. (2019) (37)
Ontogeny of the erythroid/HepG2-type glucose transporter (GLUT-1) in the rat nervous system. (1993) (37)
Apolipoprotein E element 4 allele frequency is not increased in progressive supranuclear palsy (1995) (37)
α-Calcium-Calmodulin-Dependent Kinase II is Associated with Paired Helical Filaments of Alzheimer's Disease (1996) (36)
Differential Regulation of Glutamate Receptors in Alzheimer’s Disease (2002) (36)
Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease. (2009) (36)
Insulin signaling, diabetes mellitus and risk of Alzheimer disease. (2005) (36)
Role of Oxidative Stress in Frontotemporal Dementia (1999) (35)
Assessment of serum macro and trace element homeostasis and the complexity of inter-element relations in bipolar mood disorders. (2008) (35)
A Multilevel View of the Development of Alzheimer’s Disease (2020) (35)
Emerging evidence for the neuroprotective role of α-synuclein (2006) (35)
What are the facts and artifacts of the pathogenensis and etiology of Alzheimer disease? (1998) (35)
MAPKs are differentially modulated in arctic ground squirrels during hibernation (2005) (35)
Oxidative stress and predominant Aβ42(43) deposition in myopathies with rimmed vacuoles (2003) (34)
The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease. (2004) (34)
The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention. (2011) (34)
Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease (2003) (34)
The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies (2011) (34)
Leucine-Rich Repeat Kinase 2 Colocalizes with α-Synuclein in Parkinson’s Disease, but Not Tau-Containing Deposits in Tauopathies (2008) (34)
Dissociated amyloid-β antibody levels as a serum biomarker for the progression of Alzheimer’s disease: A population-based study (2010) (34)
The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival (2009) (34)
Book Review: Is Alzheimer’s Disease a Mitochondrial Disorder? (2002) (34)
Association of apolipoprotein E with murine amyloid A protein amyloid. (1995) (33)
Distribution of lipid and raised lesions in aortas of young people of different geographic origins (WHO-ISFC PBDAY Study). World Health Organization-International Society and Federation of Cardiology. Pathobiological Determinants of Atherosclerosis in Youth. (1993) (33)
Oxidative damage and Alzheimer's disease: are antioxidant therapies useful? (2005) (33)
Autophagy in Alzheimer’s disease (2010) (33)
Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease. (2004) (33)
Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. (2019) (33)
Potential immunotargets for Alzheimer's disease treatment strategies. (2012) (32)
Gender Differences in Alzheimer Disease: The Role of Luteinizing Hormone in Disease Pathogenesis (2005) (32)
The role of novel chitin-like polysaccharides in Alzheimer disease (2007) (32)
Immunoaffinity demonstration that paired helical filaments of Alzheimer disease share epitopes with neurofilaments, MAP2 and tau (1989) (32)
Do neurons have a choice in death? (2001) (32)
Clusterin up-regulation following sub-lethal oxidative stress and lipid peroxidation in human neuroblastoma cells (2006) (32)
Mitogen‐ and stress‐activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease (2005) (32)
Frontiers in Alzheimer’s disease therapeutics (2011) (32)
Trace elements in Alzheimer'sdisease brain: A new hypothesis. (1999) (32)
Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis? (2016) (31)
The mitochondrial common deletion in Parkinson's disease and related movement disorders. (2002) (31)
Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. (2012) (31)
Early contribution of oxidative glycation in Alzheimer disease (1996) (31)
Tau phosphorylation and assembly. (2004) (31)
Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment. (2010) (31)
Advanced lipid peroxidation end-products in Alexander's disease 1 Send reprint requests to M.A. Smith, 2085 Adelbert Road, Cleveland, OH 44106, USA. Tel.: +216-368-3670; fax: +216-368-8964. 1 (1998) (31)
Biogenic metallic elements in the human brain? (2021) (30)
Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease. (2017) (30)
Melatonin reduces interleukin secretion in amyloid-β stressed mouse brain slices (2001) (30)
The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases (2020) (30)
Striation is the characteristic neuritic abnormality in Alzheimer disease (1998) (30)
Neuritic plaques in Alzheimer disease originate from neurofibrillary tangles. (1993) (30)
Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease. (2006) (30)
Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease. (2020) (30)
Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming! (2012) (29)
Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer’s disease (2015) (29)
Gonadotropins: A cohesive gender-based etiology of Alzheimer disease (2007) (29)
Serial reconstruction of β-protein amyloid plaques: relationship to microvessels and size distribution (1992) (29)
Amyloid‐β: A vascular sealant that protects against hemorrhage? (2002) (29)
Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin‐1 immunoreactivity in aortic endothelial cells of Donryu rats on a cholesterol‐enriched diet (2000) (29)
Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer’s disease (2015) (29)
Differential diagnosis between mycosis fungoides and chronic dermatitis by fractal analysis. (2003) (28)
First evidence for helical transitions in supercoiled DNA by amyloid Beta Peptide (1-42) and aluminum: a new insight in understanding Alzheimer's disease. (2004) (28)
Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection. (2004) (28)
Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress (2009) (28)
Electron Microscopic Localization of Alzheimer Neurofibrillary Tangle Components Recognized by an Antiserum to Paired Helical Filaments (1986) (28)
Alteration of superhelical state of DNA by aluminium (Al). (1993) (28)
Will antioxidants fulfill their expectations for the treatment of Alzheimer disease? (2000) (28)
Antibodies to the neuronal cytoskeleton are elicited by Alzheimer paired helical filament fractions (1987) (28)
New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection. (2011) (28)
Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology. (2016) (28)
Opportunity Rover's image analysis: Microbialites on Mars? (2014) (28)
Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein (2016) (28)
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. (1989) (27)
Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease? (2004) (27)
Evidence for the role of luteinizing hormone in Alzheimer disease. (2007) (27)
Assembly in vitro of tau protein and its implications in Alzheimer's disease. (2004) (27)
Alteration of Phospholipase C‐δ Protein Level and Specific Activity in Alzheimer's Disease (1995) (27)
Cerebral Hemorrhage and Amyloid-β (2003) (27)
A new evidence for DNA nicking property of amyloid beta-peptide (1-42): relevance to Alzheimer's disease. (2007) (27)
MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness (2020) (27)
PARK 2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer ’ s disease (2016) (27)
Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? (2005) (26)
Alzheimer's disease and oxidative stress: The old problem remains unsolved (2005) (26)
Neuroinflammatory Responses in the Alzheimer's Disease Brain Promote the Oxidative Post‐translational Modification of Amyloid Deposits (2002) (26)
A novel perspective on tau in Alzheimer's disease. (2011) (26)
Alterations in the Neuronal Cytoskeleton in Alzheimer Disease (1988) (26)
Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study. (2007) (26)
Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model. (1999) (26)
Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers (2005) (26)
Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic Diseases. (2017) (26)
β‐Amyloid 1‐42 induces physiological transcriptional regulation of BACE1 (2012) (26)
α1-Trypsin Immunoreactivity in Alzheimer Disease (1993) (26)
Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease. (2002) (25)
Inhibition of monoamine oxidase-A of rat brain by pyrethroids — anin vitro kinetic study (1993) (25)
Alzheimer disease: an imbalance of proteolytic regulation? (1994) (25)
Amyloidosis, advanced glycation end products and Alzheimer disease. (1995) (25)
Possible Involvement of ER Chaperone Grp78 on Reduced Formation of Amyloid‐β Deposits (2002) (25)
Dementia Pugilistica Revisited (2017) (25)
Molecular Understanding of Copper and Iron Interaction with α-Synuclein by Fluorescence Analysis (2008) (25)
Evidence of altered DNA integrity in the brain regions of suicidal victims of Bipolar Depression (2010) (25)
Therapeutic potential in Alzheimer disease. (2002) (24)
Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity. (2008) (24)
Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. (2008) (24)
Predicting the failure of amyloid-beta vaccine. (2002) (24)
Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology (1991) (24)
Advanced glycation modification of Rosenthal fibers in patients with Alexander disease (1997) (24)
Mathematical modeling of microtubule dynamics: Insights into physiology and disease (2010) (24)
Apolipoprotein E4 Prevents Growth of Malaria at the Intraerythrocyte Stage: Implications For Diff erences in Racial Susceptibility to Alzheimer’s Disease (2013) (24)
Prion disease and Alzheimer's disease: pathogenic overlap. (2004) (24)
The Transformative Possibilities of the Microbiota and Mycobiota for Health, Disease, Aging, and Technological Innovation (2019) (24)
Hirano body filaments contain actin and actin-associated proteins (1987) (24)
Metals and oxidative homeostasis in Alzheimer's disease (2002) (24)
Indices of Metabolic Dysfunction and Oxidative Stress (2007) (24)
Call for Elan to publish Alzheimer's trial details (2002) (23)
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease. (2010) (23)
Abnormal accumulation of phospholipase C-δ in filamentous inclusions of human neurodegenerative diseases (1993) (23)
Imaging the Alzheimer brain. (2011) (23)
Thermodynamics of Amyloid-β Fibril Elongation: Atomistic Details of the Transition State (2017) (23)
RTN1 and RTN3 protein are differentially associated with senile plaques in Alzheimer’s brains (2017) (23)
Microbes and Alzheimer's Disease (2017) (23)
P38 activation mediates amyloid-beta cytotoxicity. (2005) (23)
Asking the Right Questions (1999) (23)
Correlation between histomorphometric findings on endomyocardial biopsy and clinical findings in idiopathic dilated cardiomyopathy. (1989) (23)
Possible involvement of Wiskott–Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease (2003) (22)
The key role of oxidative stress in alzheimer's disease (2007) (22)
Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation. (2013) (22)
Will Preventing Protein Aggregates Live Up to Its Promise as Prophylaxis Against Neurodegenerative Diseases? (2003) (22)
Glucose Transporters are Abundant in Cells with (1990) (22)
Fractal analysis of fluoroangiographic patterns in anterior ischaemic optic neuropathy and optic neuritis: a pilot study (2008) (22)
Alzheimer's disease: A century of scientific and clinical research (2006) (21)
Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease (2021) (21)
Abnormal oral vascular network geometric complexity in Ehlers-Danlos syndrome. (2004) (21)
The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease (2006) (21)
Tryptamine induces axonopathy and mitochondriopathy mimicking neurodegenerative diseases via tryptophanyl-tRNA deficiency. (2013) (21)
Alzheimer's disease: an intracellular movement disorder? (2005) (21)
What is aging? What is its role in Alzheimer's disease? What can we do about it? (2005) (21)
Oxidative Stress Induces Senescence in Cultured RPE Cells (2016) (21)
Intrahippocampal amyloid-β (1-40) injections injure medial septal neurons in rats. (2011) (21)
Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains. (2016) (21)
Accumulation of intraneuronal amyloid-β is common in normal brain. (2014) (21)
Tipping the apoptotic balance in Alzheimer's disease (2007) (21)
Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target? (2012) (21)
Status and future directions of clinical trials in Alzheimer's disease. (2020) (21)
Degeneration of amyloid precursor protein containing smooth muscle cells in cerebral amyloid angiopathy (1993) (20)
Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumours is associated with selective depression of constitutive NOS immunoreactivity in vessel endothelium. (2002) (20)
Faculty Opinions recommendation of Specific Inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases. (2010) (20)
Differences in structure and function between human and murine tau. (2019) (20)
Iron: A Pathological Mediator of Alzheimer Disease? (2009) (20)
Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation (2008) (20)
Widespread distribution of reticulon‐3 in various neurodegenerative diseases (2010) (20)
A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. (2013) (19)
TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease. (2020) (19)
4‐Hydroxynonenal contributes to NGF withdrawal‐induced neuronal apoptosis (2003) (19)
CHONDROITIN SULFATE PROTEOGLYCANS ARE ASSOCIATED WITH THE LESIONS OF ALZHEIMERʼS DISEASE (1993) (19)
The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research. (2019) (19)
Pathobiology of familial hypercholesterolemic atherosclerosis. (2004) (19)
Role of protein conformational dynamics and DNA integrity in relevance to neuronal cell death in neurodegeneration. (2006) (19)
Oral Mucosal Microvascular Abnormalities: An Early Marker of Bronchopulmonary Dysplasia (2004) (19)
DNA Damage in Alzheimer Disease Lymphocytes and Its Relation to Premature Centromere Division (2013) (19)
The Microbiota–Gut–Brain Axis–Heart Shunt Part II: Prosaic Foods and the Brain–Heart Connection in Alzheimer Disease (2020) (19)
Differential Network Analyses of Alzheimer's Disease Identify Early Events in Alzheimer's Disease Pathology (2014) (19)
Aluminium content in tea leaves and in differently prepared tea infusions (1994) (19)
Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices. (2001) (19)
Amyloid β peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system (2013) (18)
Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease. (2009) (18)
Current needs for human and medical genomics research infrastructure in low and middle income countries (2016) (18)
A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson’s disease: Emerging concepts and challenges (2019) (18)
Cognitive aging and early diagnosis challenges in Alzheimer's disease. (2011) (18)
Characterization of the association of phospholipase C-δ with Alzheimer neurofibrillary tangles (1995) (18)
Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse. (2016) (18)
Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease (2009) (18)
Role of metals in neuronal apoptosis: challenges associated with neurodegeneration. (2006) (18)
Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy. (1995) (18)
The Great British Picture Show (1974) (18)
Ultrastructural localization of heme oxygenase-1 to the neurofibrillary pathology of Alzheimer disease. (1995) (18)
Staying connected: synapses in Alzheimer disease. (2004) (18)
Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases (1991) (17)
Prospects for Noninvasive Imaging of Brain Amyloid β in Alzheimer's Disease (2000) (17)
Tau modifiers as therapeutic targets for Alzheimer's disease. (2005) (17)
MITOCHONDRIA ABNORMALITIES MARK VULNERABLE NEURONS IN ALZHEIMER DISEASE (1999) (17)
Alzheimer's Disease: Advances for a New Century (2012) (17)
Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities (1992) (17)
Coexistence of cytokeratin, vimentin and neurofilament protein in human choroid plexus (1987) (17)
Making the Case for Accelerated Withdrawal of Aducanumab. (2022) (17)
Induction of NADPH cytochrome P450 reductase by the Alzheimer β‐protein. Amyloid as a ‘foreign body’ (2001) (17)
Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease. (2016) (17)
Genetic evidence for oxidative stress in Alzheimer's disease. (1999) (17)
Mitochondrial abnormalities: A primary basis for oxidative damage in Alzheimer's disease (1999) (17)
Amyloid-β Vaccination: Testing the Amyloid Hypothesis? : Heads We Win, Tails You Lose! (2006) (17)
Current research in biotechnology: Exploring the biotech forefront (2019) (16)
Histochemical and Immunocytochemical Approaches to the Study of Oxidative Stress (2000) (16)
X-ray contrast media induce aortic endothelial damage, which can be prevented with prior heparin treatment. (2003) (16)
Evidence for a novel heme-binding protein, HasAh, in Alzheimer disease. (2000) (16)
Effect of aluminium (Al) on the brain cells of the rat. (1992) (16)
Cerebrovascular and mitochondrial abnormalities in Alzheimer’s disease: a brief overview (2016) (16)
Concealment of epitope by reduction and alkylation in prion protein. (2005) (16)
Amyloid-beta: a vascular sealant that protects against hemorrhage? (2002) (16)
Is amyloid β‐protein glycated in Alzheimer's disease? (1997) (16)
BACE1 regulates the proliferation and cellular functions of Schwann cells (2017) (16)
Phase transition of the microvascular network architecture in human pathologies. (2012) (16)
Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream. (2006) (16)
Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress. (2012) (15)
Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links (2013) (15)
Therapeutic potential of oxidant mechanisms in Alzheimer’s disease (2004) (15)
Alzheimer's Disease Patients in the Crosshairs of COVID-19. (2020) (15)
The effects of impaired cerebral circulation on Alzheimer's disease pathology: evidence from animal studies. (2014) (15)
Perspectives on the amyloid-beta cascade hypothesis. (2004) (15)
The Intestinal Barrier in Air Pollution-Associated Neural Invol vement in Mexico City Residents: Mind the Gut, the Evolution of a Chan ging Paradigm Relevant to Parkinson Disease Risk (2015) (15)
ACCUMULATION OF 8-HYDROXY-GUANOSINE IN NEURONAL CYTOPLASM INDICATES MITOCHONDRIAL DAMAGE AND RADICAL PRODUCTION ARE EARLY FEATURES OF ALZHEIMER DISEASE (1998) (14)
Estrogen replacement and risk of Alzheimer disease. (2003) (14)
An algorithmic approach to understand trace elemental homeostasis in serum samples of Parkinson disease (2005) (14)
Current hypotheses and research milestones in Alzheimer's disease (2009) (14)
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology (2018) (14)
The essential role of ERK in 4‐oxo‐2‐nonenal‐mediated cytotoxicity in SH‐SY5Y human neuroblastoma cells (2009) (14)
A brief guide to the science and art of writing manuscripts in biomedicine (2020) (14)
Single-channel permeability and glycerol affinity of human aquaglyceroporin AQP3. (2019) (14)
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease (1995) (14)
Biochemistry of Neurodegeneration (2001) (14)
Treating the lesions, not the disease. (2007) (14)
Drug therapy in Alzheimer's disease [5] (multiple letters) (2004) (14)
Possible Protective Mechanisms of Heme Oxygenase‐1 in the Brain (2002) (14)
Is amyloid beta-protein glycated in Alzheimer's disease? (1997) (14)
Increased Expression of p130 in Alzheimer Disease (2007) (14)
Mitochondrial Dynamics in Alzheimer's Disease Opportunities for Future Treatment Strategies (2010) (14)
Fractal analysis of monocytes in diabetes. (2006) (13)
VULNERABLE NEURONS IN ALZHEIMER DISEASE ACCUMULATE MITOCHONDRIAL DNA WITH THE COMMON 5KB DELETION (1998) (13)
Ferric cycle activity and Alzheimer disease. (2005) (13)
Chlamydia pneumoniae promotes dysfunction of pancreatic beta cells. (2015) (13)
Elastase is associated with the neurofibrillary pathology of Alzheimer disease: a putative link between proteolytic imbalance and oxidative stress. (1996) (13)
The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target. (2006) (13)
Abnormal oral mucosal light reflectance: a new clinical sign of Ehlers-Danlos syndrome. (2004) (13)
Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment (2006) (13)
Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress (2007) (13)
Fractal Dimension of Lymphocytic Nuclear Membrane in Mycosis Fungoides and Chronic Dermatitis (1998) (13)
Microvascular abnormalities in Rett syndrome. (2013) (13)
Toll-like receptors in Alzheimer's disease (2020) (13)
Tropomyosin isoform expression in normal and neoplastic astrocytes. (1990) (13)
Emerging evidence for the neuroprotective role of alpha-synuclein. (2006) (13)
Divalent metal transporter, iron, and Parkinson's disease: A pathological relationship (2010) (13)
Stem cell niches as clinical targets: the future of anti-ischemic therapy? (2008) (13)
The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimers Disease (2002) (13)
Abnormal oral vascular network pattern geometry: a new clinical sign of down syndrome. (2006) (12)
Studies on the Role of Amino Acid Stereospecificity in Amyloid Beta Aggregation (2007) (12)
Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry. (2019) (12)
Menopause, estrogen, and gonadotropins in Alzheimer's disease. (2008) (12)
The films of Alfred Hitchcock (1970) (12)
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. (1997) (12)
Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau (2014) (12)
Paired helical filaments: Do they contain neurofilament epitopes? (1986) (12)
Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer’s Disease (2017) (12)
Mitochondrial Drugs for Alzheimer Disease (2009) (12)
Dystrophic neurites define diffuse as well as core-containing senile plaques in Alzheimer's disease. (1995) (12)
alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease. (1996) (12)
Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. (2019) (12)
Alzheimer disease: protein-protein interaction and oxidative stress. (1996) (12)
The "Down's" side of mitochondria. (2002) (12)
Amyloid-beta: a (life) preserver for the brain. (2002) (12)
Editorial: a new era for medicinal chemistry. (2012) (11)
RNA Oxidation in Alzheimer and Parkinson Diseases (1999) (11)
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints (2021) (11)
Trypsin interaction with the senile plaques of Alzheimer disease is mediated by beta-protein precursor. (1996) (11)
Differential Diagnosis: Shape and Function, Fractal Tools in the Pathology Lab. (2015) (11)
A second look into the oxidant mechanisms in Alzheimer's disease. (2005) (11)
Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders (2018) (11)
Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer’s disease brains (2021) (11)
Dystrophic neurites infiltrate extracellular neurofibrillary tangles in Alzheimer disease (1991) (11)
Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer's Diseased Brains by MALDI-TOF MS with MS/MS. (2018) (11)
Oxidant and antioxidant responses in Alzheimer disease (2001) (11)
World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth (PBDAY) Study. Histomorphometric investigation of the aorta and coronary arteries in young people from different geographical locations. (1999) (11)
The Estrogen Myth (2006) (11)
Academic Journals Plagued by Bogus Impact Factors (2017) (11)
Ubiquitin in Alzheimer and other Neurodegenerative Diseases (1987) (10)
Mathematical approach to understand the kinetics of α-synuclein aggregation: Relevance to Parkinson's disease (2008) (10)
The Four Pillars of Alzheimer’s Prevention (2017) (10)
CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease (2010) (10)
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers (2020) (10)
Neuropsychiatric Disturbances and Diabetes Mellitus: The Role of Oxidative Stress (2019) (10)
A New Model of Oxidative Stress in Rat Pups (2008) (10)
Elongation affinity, activation barrier, and stability of Aβ42 oligomers/fibrils in physiological saline. (2017) (10)
Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization (2021) (10)
Ill‐fated amyloid‐β vaccine (2002) (10)
Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia (2007) (10)
The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies (2020) (10)
Heme Deficiency in Alzheimer's Disease: A Possible Connection to Porphyria (2006) (10)
Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicity. (2002) (10)
Preliminary observations on the ultrastructural modifications of the freeze-cleaved circulating platelets surface in hypercholesterolemic rabbits treated with AD6. (1978) (10)
The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies (2020) (10)
Aberrant Phosphoinositide Metabolism in Alzheimer's Disease a (1993) (9)
Faculty Opinions recommendation of Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. (2004) (9)
From Neurodegeneration to Brain Health: An Integrated Approach. (2015) (9)
Presenilin mutation: a deadly first hit in Alzheimer disease. A commentary on "aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice". (2006) (9)
The complete Phantom of the Opera (1987) (9)
α1-Antitrypsin and α1-antichymotrypsin are in the lesions of Alzheimer's disease (1992) (9)
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets (2009) (9)
Entropy of corneal nerve fibers distribution observed by laser scanning confocal microscopy: A noninvasive quantitative method to characterize the corneal innervation in Sjogren's syndrome patients (2015) (9)
Pathobiological determinants of atherosclerosis in youth (PBDAY WHO-ISFC) study: histomorphometric investigation of the aorta and coronary artery in young people (1994) (9)
Insights into the structural patterns of the antileishmanial activity of bi- and tricyclic N-heterocycles. (2016) (9)
Molecular Aspects of Neurodegeneration and Neuroprotection (2012) (9)
Modeling cholesterol metabolism by gene expression profiling in the hippocampus. (2011) (9)
Fractal analysis of epithelial-connective tissue interface in basal cell carcinoma (1998) (9)
The Role of Oxidative Damage to Nucleic Acids in the Pathogenesis of Neurological Disease (2007) (9)
Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer’s Disease (2011) (9)
Towards an Integrative Understanding of tRNA Aminoacylation–Diet–Host–Gut Microbiome Interactions in Neurodegeneration (2018) (9)
Correction of erythrocyte shape abnormalities in familial hypercholesterolemia after LDL-apheresis: Does it influence cerebral hemodynamics? (2007) (9)
Activation of P38 kinase links π phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease (2000) (8)
Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease (2009) (8)
Mitotic and gender parallels in Alzheimer disease: therapeutic opportunities. (2004) (8)
Ultrastructural analysis of a murine model of congenital hydrocephalus produced by overexpression of transforming growth factor-beta1 in the central nervous system. (2006) (8)
Expression of growth hormone gene in the baboon eye (2018) (8)
CSF Biomarkers: Low Amyloid-ÃÂ²1-42 and BDNF and High IFN ÃÂ³Differentiate Children Exposed to Mexico City High Air Pollution VControls. AlzheimerÃ¢ÂÂs Disease Uncertainties (2015) (8)
Universal isolation of cross-linked peptides: application to neurofibrillary tangles. (1999) (8)
Affinity and path of binding xylopyranose unto E. coli xylose permease. (2017) (8)
Cellular prion protein is essential for oligomeric amyloid- b -induced neuronal cell death (2012) (8)
Immunolocalization of the amyloid precursor protein within the senile plaque. (1989) (8)
Forever Ealing: A Celebration of the Great British Film Studio (1981) (8)
MSDC-0160 and MSDC-0602 Binding with Human Mitochondrial Pyruvate Carrier (MPC) 1 and 2 Heterodimer: PPARγ Activating and Sparing TZDs as Therapeutics (2017) (8)
Molecular Mapping Alzheimer's Disease: MALDI Imaging of Formalin-fixed, Paraffin-embedded Human Hippocampal Tissue (2016) (8)
Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain. (2009) (8)
Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease. (2020) (8)
Open peer commentary Copernicus revisited: amyloid beta in Alzheimer's disease (2001) (8)
Fractal dimension of bone texture in radiographs correlates to ultrasound broadband attenuation T-score. (2013) (8)
An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1. (2018) (8)
Gibbs Free-Energy Gradient along the Path of Glucose Transport through Human Glucose Transporter 3 (2018) (8)
Oxidative Stress Signaling in Blast TBI-Induced Tau Phosphorylation (2021) (8)
Tau-reactive neurofibrillary tangles in cerebellar cortex from patients with Alzheimer's disease (1989) (8)
An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1. (2018) (8)
Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice (1996) (8)
Gait Disorders in Alzheimer's Disease and Other Dementias: There is Something in the Way You Walk. (2019) (8)
Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological Study. (2019) (7)
Antioxidants in the Prevention and Treatment of Alzheimer’s Disease (2017) (7)
A diet at amyloid beta? (2001) (7)
The sterol regulatory element‐binding protein 2 is dysregulated by tau alterations in Alzheimer disease (2019) (7)
Therapeutic potential of oxidative stress reduction in Alzheimer's disease (2006) (7)
No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study. (2019) (7)
Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease. (2000) (7)
Global warming and neurodegenerative disorders: speculations on their linkage (2014) (7)
Effect of the herbicide 4-CPA on human erythrocyte antioxidant enzymes in vitro (2001) (7)
Updating on in-vivo and in-vitro effects of heparin and other glycosaminoglycans (mesoglycan) on arterial endothelium: a morphometrical study. (1992) (7)
TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease. (2017) (7)
Immunohistochemical recognition of ethylnitrosourea induced rat brain microtumors by anti-Leu 7 monoclonal antibody. (1990) (7)
When hypotheses dominate (2004) (7)
Journal of Alzheimer's Disease: Editorial (2004) (7)
Signal Transduction in Alzheimer’s Disease (2002) (7)
Redox active iron at the center of oxidative stress in Alzheimer disease (2005) (7)
Alternative neural circuitry that might be impaired in the development of Alzheimer disease (2015) (7)
Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice. (2019) (7)
Paraffin-embedded tissue (PET) blot method: Application to Alzheimer disease (2010) (7)
Altered redox balance in disease: Can we change the new equilibria? (2009) (7)
Alexander disease: Alzheimer disease of the developing brain? (1999) (7)
Alzheimer's disease and prion proteins: a meeting made in muscle. (1994) (7)
Ciprofloxacin Does Not Exert Nephrotoxicity in Rats (2005) (7)
Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein. (1989) (7)
Optogenetics: implications for Alzheimer’s disease research and therapy (2022) (7)
Foreword [The Largest Unmet Market: Chronic Diseases of Aging] (2012) (7)
[Oxidative stress and Alzheimer's disease]. (2016) (6)
Morphological features of regeneration of rabbit aortic endothelium after cryoinduced vascular damage. (1999) (6)
160 ULTRASTRUCTURAL LOCALIZATION OF CYTOSKELETAL MARKERS ON ALZHEIMERʼS PAIRED HELICAL FILAMENTS (1984) (6)
Platelet function abnormalities in 6-12 month-old Watanabe heritable hyperlipidemic (WHHL) rabbits. (1991) (6)
Apoptotic and Oxidative Indicators in Alzheimer’s Disease (2002) (6)
Fractals and Pathology (2016) (6)
Amyotrophic lateral sclerosis: a novel hypothesis involving a gained 'loss of function' in the JNK/SAPK pathway (2003) (6)
ROLE OF VASCULAR SMOOTH MUSCLE CELLS IN AMYLOID DEPOSITION IN CEREBRAL AMYLOID ANGIOPATHY: 211 (1990) (6)
Mechanisms of DNA Damage and Repair in Alzheimer Disease (2006) (6)
Interdisciplinary Approaches to COVID-19. (2021) (6)
Abnormal Oral Mucosal Light Reflectance in Infantile Hypertrophic Pyloric Stenosis (2004) (6)
Alteration of the neurofilament-microtubule network in Alzheimer disease and other neurodegenerative disorders (1987) (6)
Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration. (2016) (6)
Neurogenesis in Human Hippocampus: Implications for Alzheimer Disease Pathogenesis (2006) (6)
Cyclin Dependent Kinase 11, Neuroinflammation and Alzheimer's Disease: A Review (2015) (6)
Tackling the elusive challenges relevant to conquering the 100-plus year old problem of Alzheimer's disease. (2013) (6)
From Oxidative Stress to Ageing via Lifestyle, Nutraceuticals, Polypharmacy, and Neuropsychological Factors (2018) (6)
P3-296 Luteinizing hormone mediates Alzheimer-type changes in neurons (2006) (6)
Fractal analysis of circulating platelets in type 2 diabetic patients. (2015) (6)
Heads We Win, Tails You Lose! (2006) (6)
Precision medicine using individualized biosimulations of drug dosing: Alzheimer's disease (2014) (6)
Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease. (1995) (6)
Faculty Opinions recommendation of Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation. (2005) (6)
Functional and Genomic Features of Human Genes Mutated in Neuropsychiatric Disorders (2016) (6)
Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement. (2022) (6)
Alzheimer's Disease and Vascular Deficiency: Lessons from Imaging Studies and Down Syndrome (2012) (6)
S4-02-01 Alzheimer disease: the two hit hypothesis (2004) (6)
Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data. (2018) (5)
"The Grand Regulator": State Schooling and the Normal-School Idea in Nova Scotia, 1838-1855 (2003) (5)
“A Concession to Circumstances”: Nova Scotia’s “UnlimitedSupply” of Women Teachers, 1870-1960 (2003) (5)
Alterations of the X Chromosome in Lymphocytes of Alzheimer's Disease Patients. (2015) (5)
Perspectives on animal behaviour. A first course (1974) (5)
Platelet plasma membrane changes in human type IIa hypercholesterolemia. (1986) (5)
The pathology of Alzheimer disease elicits an in vivo immunological response (2007) (5)
Oncogenic parallels in Alzheimer disease (2006) (5)
Congenital Oral Mucosal Abnormalities in True Umbilical Cord Knots (2004) (5)
Protein Modifications and Interactions in Alzheimer’s Disease (1996) (5)
Dual fuel engine control systems for transportation applications (1987) (5)
Effects of aluminium salts on synaptosomal enzymes--an in vitro kinetic study. (1990) (5)
A competitive cinema (1966) (5)
MDA and GSH levels in newly diagnosed Alzheimer's disease patients: A population-based study (2010) (5)
Particulate emissions of a dual fuel caterpillar 3208 engine (1988) (5)
Microscopic Investigations in Neurodegenerative Diseases (2007) (5)
Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression". (2006) (5)
Prospects on the origin of Alzheimer's disease. (2010) (5)
Ultrastructural modifications of the platelet plasma membrane in vascular diseases and the effect of a carbochromen derivative as studied by freeze-fracture and computer measurement. (1986) (5)
Plaques and tangles: birthmarks of the aging soul. Preface. (2014) (5)
Hackers Spy Scientists. (2016) (5)
Observations on the effects of some antiaggregating drugs on platelet specific protein discharge after a very weak stimulus. (1985) (5)
Dangers of the amyloid-β vaccination (2002) (5)
Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease. (2010) (5)
Genetic Risk of Alzheimer’s Disease: Three Wishes Now That the Genie is Out of the Bottle (2018) (5)
Protocol for quantitative analysis of paired helical filament solubilization: a method applicable to insoluble amyloids and inclusion bodies. (1997) (5)
Drug therapy in Alzheimer's disease. (2004) (5)
α-Synuclein and tau, two targets for dementia (2020) (5)
Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and α-synuclein toward in vivo analysis. (2018) (5)
Drug-Abuse Nanotechnology: Opportunities and Challenges. (2018) (5)
Ubiquitin and Other Stress Proteins in Cultured Nervous-Tissue after Heat-Shock and Aluminum Intoxication (1988) (5)
Elevation of-Amyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment (2010) (5)
Nonlinear analysis of the Viking Lander 2 Labeled Release data (2003) (5)
Neurofibrillary Tangle Formation as a Protective Response to Oxidative Stress in Alzheimer’s Disease (2009) (5)
Microbialites at Gusev Crater, Mars. (2015) (5)
MICROFILAMENT INVOLVEMENT IN HIRANO BODY FORMATION (1987) (5)
Research report Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease (1998) (5)
Neuroinflammatory Environments Promote Amyloid-ß Deposition and Posttranslational Modification (2003) (5)
NEUROFIBRILLARY TANGLES, NEUROPIL THREADS AND SENILE PLAQUES ALL CONTAIN ABUNDANT BINDING SITES FOR BASIC FIBROBLAST GROWTH FACTOR (b-FGF): 173 (1990) (5)
1,3‐propanediol binds deep inside the channel to inhibit water permeation through aquaporins (2016) (5)
Oxidative Stress in Alzheimer’s Disease: A Critical Appraisal of the Causes and the Consequences (2011) (4)
NEURONAL CYTOSKELETAL INVOLVEMENT IN LEWY BODY FORMATION: 126 (1987) (4)
Commentary: “Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer’s disease. Just hypotheses or molecular pathways to be identified?” By Claudio Costantini, Rekha M.K. Kolasani, and Luigi Puglielli (2005) (4)
Alzheimer’s Disease: An Overview (2009) (4)
Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease (2008) (4)
Two-Dimensional Fractal Geometric Analysis of Bone Marrow Tissue in Hyperplasia, Refractory Anemia and Acute Leukemia (2002) (4)
Untangling the Vascular Web from Alzheimer Disease and Oxidative Stress (2012) (4)
In Vivo and In Silico Evidence: Hippocampal Cholesterol Metabolism Decreases with Aging and Increases with Alzheimers Disease -- Modeling Brain Aging and Disease (2011) (4)
Molecular Pathology of Alzheimer's Disease (2013) (4)
Erratum: Autophagocytosis of mitochondria is prominent in Alzheimer disease (Journal of Neuropathology and Experimental Neurology (2007) 66, (525-532)) (2007) (4)
Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease. (2011) (4)
Prospects for antioxidant therapy in mild cognitive impairment and alzheimer's disease (2007) (4)
Sources contributing to the initiation and propagation of oxidative stress in Alzheimer disease (2003) (4)
The increase of the openings of the surface-connected canalicular system in weakly stimulated platelets is prevented by a carbochromen derivative. A computerized morphometric analysis of freeze-etched human platelet plasma-membrane. (1987) (4)
The Role of Oxidative Stress in the Pathological Sequelae of Alzheimer Disease (1998) (4)
Abnormal vascular network complexity: a phenotypical marker in hereditary nonpolyposis colorectal cancer syndrome (2003) (4)
Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration (2021) (4)
The Role of the Iron Stain in Assessing Intracranial Hemorrhage (2016) (4)
Chronic or Late Lyme Neuroborreliosis: Present and Future (2012) (4)
Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose! (2006) (4)
Ophthalmic manifestations of COVID-19; a less-appreciated yet significant challenge (2021) (4)
Nanoparticles for the Treatment of Alzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives (2007) (4)
OXIDATION OF NUCLEIC ACIDS IN NEURONS PRECEDES AMYLOID $BT DEPOSITION IN DOWN SYNDROME (1999) (4)
Structures/textures of living/fossil microbialites and their implications in biogenicity: An astrobiological point of view (2015) (4)
Alpha 1-trypsin immunoreactivity in Alzheimer disease. (1993) (4)
Natural oxidant balance in Parkinson disease. (2009) (4)
Nuclear microscopy of diffuse plaques in the brains of transgenic mice (2005) (4)
Evidence for Oxidative Damage in the Autistic Brain (2009) (4)
Antibodies to Potato Virus Y Bind the Amyloid β Peptide (2008) (4)
Ultrastructural modifications of the freeze-cleaved circulating platelets surface in hypercholesterolemic rabbits (1979) (4)
Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET: Transcriptome-To-Reactome™ Biosimulation of Neurons (2015) (4)
Competitive exclusion in poultry production. (2006) (4)
Oxidative Stress Mechanisms and Potential Therapeutic Modalities in Alzheimer Disease (2004) (4)
Methemoglobinemia—A biomarker and a link to ferric iron accumulation in Alzheimer’s disease (2014) (4)
Effects of testosterone on the liver of castrated rats: morphologic study. (1991) (4)
Natural Gas Conversion Systems for Heavy Duty Truck Engines (1991) (4)
The rearing of colostrum-deprived piglets. (1968) (4)
Treatment advances in Alzheimer's disease based on the oxidative stress model (2009) (4)
Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review (2021) (4)
Colonic Adenocarcinoma of a Neovagina in a Patient with Mullerian Agenesis (2014) (4)
Therapeutic options in Alzheimers disease (2006) (4)
Geometric complexity is increased in in vitro activated platelets (2015) (4)
Failure of A β Removal to Improve Alzheimer's Dementia Opens the Door to New Thinking (2012) (4)
Geometric complexity identifies platelet activation in familial hypercholesterolemic patients (2015) (4)
[Is the lesion produced by oxidation a central part in the pathogenesis of Alzheimer's disease?]. (1999) (3)
Medical Hypotheses and Research (2005) (3)
Some aspects of the evolution with age of arterial lesions in Watanabe heritable hyperlipidemic rabbits: Morphological and morphometrical observations of aortic thoracic lesions (1991) (3)
Iron chelation and nanoparticle target delivery in the development of new multifunctional disease-modifying drugs for Alzheimer's disease. (2012) (3)
Arachidonic acid metabolism in Ascidia ceratodes eggs: role of lipid peroxidation. (1988) (3)
Treating Alzheimer Disease: Is Diet and Exercise more Effective than Small Molecule Therapy? (2013) (3)
Hypoxic preconditioning averts sporadic Alzheimer's disease-like phenotype in rats: a focus on mitochondria. (2022) (3)
Pathogenesis of Alzheimer’s Disease (2014) (3)
Human amyloid-derived aßcontains tyrosine cross-linked oligomers (2000) (3)
Is exercise‐in‐a‐bottle likely to proffer new insights into Alzheimer's disease? (2013) (3)
Metal-Catalyzed Redox Activity in Neurodegenerative Disease (2003) (3)
Amyloids, Aggregates and Neuronal Inclusions: Good or Bad News for Neurons? (2003) (3)
Effects of prostacyclin on ultrastructural features of human platelets in vitro. (1981) (3)
A new clinical sign in Down syndrome patients and their unaffected parents (2003) (3)
Concomitant Infections Should not Deter Clinicians from Diagnosing Kawasaki Disease. (2016) (3)
The largest unmet market: chronic diseases of aging. (2013) (3)
Influence of CDP-choline administration on the aortic wall lesions in dietically hypercholesterolaemic rabbits: a morphometric evaluation. (1989) (3)
Fake Universities as an Emerging Issue (2016) (3)
Hibernation, a Model of Neuroprotection (2001) (3)
Methods in Molecular Medicine, Vol. 32 Alzheimer's Disease: Methods and Protocols (2000) (3)
The Great British Picture Show: Boomtime and Slumptime (2013) (3)
Erratum: Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (Journal of Neurochemistry 85 (1101-1108)) (2003) (3)
Unworthy peer review process and publishing method (2016) (3)
National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in México. (2020) (3)
Alzheimer's Disease Pharmacology (2021) (3)
Mark Anthony Smith (1965-2010): Visionary, Alzheimer researcher, and editor-in-chief of the Journal of Alzheimer's Disease. (2011) (3)
Fractal Dimension of Epithelial-Connective Tissue Interface in Basal Cell Carcinoma of the Skin (2013) (3)
Cerebrotendinous xanthomatosis: a critical update (2008) (3)
Biochemistry of neurodegeneration [2] (multiple letters) (2001) (3)
Mechanisms Involved in Gender Differences in Alzheimer's Disease: The Role of Leuteinizing and Follicle Stimulating Hormones (2004) (3)
The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview (2012) (3)
Social factors in intensive poultry husbandry (1977) (3)
Pathology's new role: defining disease process and protective responses. (2008) (3)
Solving the insoluble. (2006) (3)
Neurodegenerative Diseases: Mechanisms and Therapies (2006) (3)
Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer's Disease (2011) (3)
Oral vascular network geometry in infantile hypertrophic pyloric stenosis. (2003) (3)
Research report Accelerated a-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells (2004) (3)
Oxidative Damage and Antioxidant Responses in Alzheimer's Disease (2002) (3)
Modified Ultrastructural Features, After Plasma-Exchange, of Circulating Platelets from Hypercholesterolemic (Type IIa) Patients: Freeze-Etching and Ultra-Thin Section Study (1984) (3)
Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy (2010) (3)
64 Pulse Oximetry Signals: Chaotic Analysis in The Evaluation of Neonatal Illness Severity (2004) (3)
Potential long‐term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans (2021) (3)
Alzheimer Disease: Oxidative Stress and Compensatory Responses (2009) (3)
ALZHEIMER DISEASE PAIRED HELICAL FILAMENT FRACTIONS CONTAIN INSOLUBLE TUBULIN: 160 (1989) (3)
The great British picture show : from the 90s to the 70s (1974) (2)
Injected Heavy-Duty Propane Engine (1996) (2)
Transport and pre-slaughter handling. (1990) (2)
Preliminary morphometric data on lipid lesion distribution in aortas of young people (WHO-ISFC PBDAY study). (1993) (2)
Oral vascular network abnormalities and achondroplasia. (2003) (2)
ORAL MICROVASCULAR NETWORK GEOMETRY ABNORMALITIES IN INFANTILE HYPERTROPHIC PYLORIC STENOSIS (2004) (2)
Monocyte entropy in type 2 diabetic patients (2015) (2)
Ultrastructural Features of Bovine Aortic Endothelial Cells Studied by Freeze-etching Technique (1983) (2)
On the involvement of platelets in atherogenesis: some ultrastructural features. (1984) (2)
World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth (PBDAY) Study. Lipid and raised lesion distribution in the right coronary artery of young people. (1999) (2)
Minima of eclipsing binaries, variability of V840 Her and NSV5740, new ephemerides for V997 Cyg, V1037, V1098, V1100 Her (2011) (2)
Carotid atherosclerotic lesions: comparative evaluation of echographic, histomorphometric and angiographic data of endoarterectomy samples. (1986) (2)
Nonlinear Analysis of tRNAs Nucleotide Sequences by Random Walks: Randomness and Order in the Primitive Informational Polymers (2015) (2)
NODE DEGREE DISTRIBUTION IN COMPLEX MICROVASCULAR NETWORKS: A POTENTIAL NEW DIAGNOSTIC TOOL FOR EXTRACELLULAR MATRIX-RELATED DISEASES (2006) (2)
Decreased Geometric Complexity of Corneal Nerve Fibers Distribution in Sjogren’s syndrome Patients (2016) (2)
Circulating platelets plasma-membrane of normocholesterolemic and hypercholesterolemic rabbits tested with aspirin: a freeze etching study of the platelet plasma-membrane "protuberances". (1980) (2)
Abnormal oral mucosal light reflectance in Achondroplasia (2004) (2)
Scientific Information Security in Information Science and Academic Publishing. (2016) (2)
Fractal Analysis and Biophysical Investigation of Muscular Tissue Damaged due to Low Temperature: A Pilot Study (2012) (2)
Fractal Analysis of the Bone Marrow in Refractory Anemia and Acute Leukemia (2000) (2)
The effect of agonists and antagonists on the morphology of non-transformed human smooth muscle cell in vitro. (2001) (2)
Structures and free energy landscapes of aqueous zinc(II)-bound amyloid-β(1–40) and zinc(II)-bound amyloid-β(1–42) with dynamics (2012) (2)
Role of Heme Catabolism in Neurodegenerative Diseases (2002) (2)
A new type of neuronal cytoplasmic inclusion: histological, ultrastructural, and immunocytochemical studies (2004) (2)
Hippocampal Unicellular Recordings and Hippocampal-dependent Innate Behaviors in an Adolescent Mouse Model of Alzheimer's disease. (2020) (2)
HIGH MOLECULAR WEIGHT NEUROFILAMENT PROTEINS (2001) (2)
8 – Prion and Alzheimer Diseases: The Road to Pathogenesis is Paved with Copper (2002) (2)
P3-219 Acetylation: a novel posttranslational modification in Alzheimer disease (2002) (2)
Lipoic Acid and N‐Acetyl Cysteine Protect Against Mitochondrial‐Related Oxidative Stress in Fibroblasts from Alzheimer Disease Patients (2007) (2)
INTERACTION OF t WITH AMYLOID DEPOSITS (1993) (2)
Preface. Alzheimer's disease: advances for a new century. (2013) (2)
Iron·ic facts about dementia (2018) (2)
Causes and consequences of oxidative stress in Alzheimers disease 1,2 1 Guest Editors: Mark A. Smit (2002) (2)
The origin of oxidative stress in neurodegenerative disease: Mark Anthony Smith 1965–2010 (2011) (2)
Editorial: Oxidative Stress Revisited—Major Role in Vascular Diseases (2019) (2)
P3-422: Impaired balance of mitochondrial fission and fusion in susceptible neurons of Alzheimer disease (2008) (2)
Alzheimer's and Parkinson's Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier - Ligand Docking to Screen Natural Compounds Related to Classic Inhibitors (2017) (2)
Oxidative Stress and Balance in Neurodegenerative Diseases (2011) (2)
Implication of ferroptosis iron‐dependent programmed cell death mechanism in neurodegeneration (2020) (2)
Short Communication Immunocytochemical Evidence That the (3-Protein Precursor Is an Integral Component of Neurofibrillary Tangles of Alzheimer's Disease (2007) (2)
ELECTRON MICROSCOPIC LOCALIZATION OF TAU IN ALZHEIMER NFT AND PHF.: 6 (1987) (2)
Role of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases (2008) (2)
In Situ Localization of Nonenzymatic Peroxidase‐Like Activity of Tissue‐Bound Transition Metals (2004) (2)
Molecular docking analysis of mitochondrial pyruvate carrier (MPC) 1 and 2 with pyruvate and inhibitors: Thiazolidinediones currently in clinical trials to delay mild cognitive impairment and Alzheimer’s disease (2015) (2)
Erratum: Prion protein glycosylation is sensitive to redox change (Journal of Biological Chemistry (1999) 274 (34846-34850)) (2000) (2)
Strawberry (Fragaria ananassa duch.) Alba extract attenuates DNA damage in lymphocytes of patients with Alzheimer's disease. (2021) (2)
Methemoglobinemia as biomarker and precursor of brain capillary oxidative damage link to ferric iron accumulation and originator of neurodegenerative disease (2017) (2)
Alzheimer's and Parkinson's Disease Novel Therapeutic Target (2021) (2)
Mitochondria and Neurodegenerative Diseases (2010) (2)
Oxidative Stress in Parkinson’s Disease (2009) (2)
Ill-fated amyloid-beta vaccine. (2002) (2)
Potential role of iron in a Mediterranean-style diet. (2010) (2)
USING CSF MARKERS TO VALIDATE METABOLIC AND SYNAPTIC DYSFUNCTION HYPOTHESES OF ALZHEIMER’S DISEASE (AD): META-ANALYSIS (2017) (2)
A Pleotrophic Age for Alzheimer and Parkinson disease (2012) (2)
7 Parallels Between Neurodevelopment and Neurodegeneration: A Case Study of Alzheimer's Disease (2008) (2)
IMUNOHISTOCHEMICAL EVIDENCE OF OXIDATIVE STRESS IN PARKINSONʼS DISEASE (PD) (1996) (2)
STRAIGHT FILAMENTS OF ALZHEIMER NEUROFIBRILLARY TANGLES.: 7 (1987) (2)
Cellular Respiration and Tumor Suppressor Genes (2009) (2)
"Hypothesis Testing" not "Disease Modifying" in Alzheimer's Disease (2010) (2)
Therapeutic Antiaging Strategies (2022) (2)
Down syndrome and Alzheimer disease: A "multi-hit" hypothesis based on multiple contributing factors resulting in pleotrophic consequences (2011) (2)
Ethanol-fixed, paraffin-embedded tissue imaging: implications for Alzheimer's disease research. (2020) (2)
IRON REGULATORY PROTEINS IN ALZHEIMER DISEASE (1998) (2)
Hydroxynonenal-Generated Crosslinking Fluorophore and Mitochondria-derived Lipoic Acid Accumulation in Alzheimer Disease Reveal a Dichotomy of Protein Turnover (2010) (2)
Late phase cell cycle proteins in Alzheimer’s disease: a possible target for therapy? (2016) (2)
Faculty Opinions recommendation of Oxidative stress mediates tau-induced neurodegeneration in Drosophila. (2007) (2)
Erratum: Advanced maillard reaction end products are associated with Alzheimer disease pathology (Proceedings of the National Academy of Sciences of the United States of America (June 7, 1994) 91 (5710-5714) (1995) (2)
Antioxidant Therapies in the Prevention and Treatment of Alzheimer Disease (2005) (2)
Neuropathological changes provide insights into key mechanisms related to Alzheimer's disease and related dementia. (2022) (2)
In Memoriam: Mark A. Smith, PhD (2011) (2)
Phytodiversity Assessment in Abandoned Solid Waste Dumpsites in Port Harcourt, Nigeria (2014) (2)
Wealth From Waste: Or, Gathering Up The Fragments... (2012) (2)
Recent Advances in Medicinal Chemistry (2017) (2)
Letters in Drug Design & Discovery (2017) (2)
Studies on the Bottom-Up and Top-Down Neural Information Flow Alterations in Neurodegeneration. (2020) (2)
Neuroprotection and Neuroregeneration in Alzheimer's Disease (2012) (2)
Hyperphosphorylated Tau Relates to Improved Cognitive Performance and Reduced Hippocampal Excitability in the Young rTg4510 Mouse Model of Tauopathy. (2022) (2)
Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema and Stroke? (2023) (1)
P1-266 The critical role of the ERK pathway in the pathogenesis of Alzheimer's disease (2004) (1)
Some pathogenetic aspects of atherosclerotic lesions. Platelets and atherogenesis. Differences in atherogenesis in different body districts. Regression of arterial lesions in animal models. (1987) (1)
Alzheimer’s and Consciousness: How Much Subjectivity Is Objective? (2021) (1)
Neurochemistry of dementia: establishing the links. (1989) (1)
CELLULAR ELEMENTS INVOLVED IN AMYLOID DEPOSITION IN THE SENILE PLAQUE: 220 (1990) (1)
What oxidative stress tells us about therapeutic targets for Alzheimer's disease (2000) (1)
Quantitative and qualitative evaluation of histomorphometric and echographic data on endoarterectomy samples (1985) (1)
A Quantum Mechanical Aspect of Enzyme Action: Enzymes as Information Driven Quantal Measurement Engines (2014) (1)
Inge Grundke-Iqbal: A Legacy of Tau in the Etiology of Alzheimer Disease (1937–2012) (2012) (1)
Oxidative Stress and Alzheimer Disease: Mechanisms and Therapeutic Opportunities (2011) (1)
Ubiquitin Reactive Neurites In Cerebral Cortex Of Huntingtonʼs Chorea: do they correlate with dementia? (1993) (1)
Role of Amyloid‐β in Alzheimer's Disease (2005) (1)
Neuronal Survival and Death in Alzheimer Disease (2002) (1)
Raúl Mena: 1953-2014. (2015) (1)
Unraveling the Role of Mitochondria in Alzheimer’s Disease (2020) (1)
112 MICE IMMUNIZED WITH ISOLATED PAIRED HELICAL FILAMENTS OF ALZHEIMERʼS DISEASE PRODUCE ANTIBODIES TO NORMAL AXONS (1983) (1)
The Fallacy of Amyloid and Cognition in Alzheimer’s Disease (2006) (1)
AMYLOID PRECURSOR PROTEIN: IMMUNOLOCALIZATION SURROUNDING SENILE PLAQUE CORE (1988) (1)
Ultrastructural computerized morphometry of platelets in chronic myelogenous leukemia making use of ultra-thin sections and freeze-fracture procedure. A preliminary approach. (1988) (1)
Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathy (2006) (1)
Comprar Current Hypotheses and Research Milestones in Alzheimer's Disease | Maccioni, Ricardo B. | 9780387879949 | Springer (2009) (1)
Platelet entropy is increased in familial hypercholesterolemia and in type 2 diabetic patients. (2015) (1)
Chronic traumatic encephalopathy: Is a role for biomarkers premature? (2014) (1)
Increased entropy in in vitro activated platelets (2014) (1)
Faculty Opinions recommendation of Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction. (2008) (1)
Emerging microstructure in biological tissue under thermo-mechanical actions (2009) (1)
Mark A. Smith: the scientist, the man. (2011) (1)
Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline. (2021) (1)
Autophagy in Alzheimer’s disease: A Cleaning Service Out-of-order? (2015) (1)
New York in the sixties (2001) (1)
Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria (2016) (1)
Oxidative Stress and Neuronal Adaptation in Alzheimer Disease (2003) (1)
Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles. (1995) (1)
Posttranslational modifications of α-tubulin in alzheimer disease (2015) (1)
Molecular Pathways in Normal Aging and Neurodegeneration: Mechanisms and Therapeutics. (2017) (1)
Signal Transduction in Alzheimers Disease (2002) (1)
Promises and pitfalls of therapeutics to modify oxidant balance in chronic disease. (2000) (1)
Thromboresistance of the arterial wall: the role of heparin and glycosaminoglycans. (1991) (1)
REDOX-ACTIVE IRON IS ASSOCIATED WITH THE PATHOLOGICAL LESIONS IN ALZHEIMER DISEASE (1997) (1)
Preventative effect of mitochondrial antioxidants in apoe deficiency mouse model of brain hypoperfusion (2009) (1)
Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain (2013) (1)
Leptin Rescues Neurons from Alzheimer's Disease Related Pathways Triggered by Lipid Burden (2013) (1)
P3-317: Failure in the control of cell cycle causes neurodegeneration (2008) (1)
Fractal Analysis of Vascular Network Pattern in Human Diseases (2005) (1)
Neurodegenerative processes in Alzheimer's disease: an overview of pathogenesis with strategic biomarker potential (2011) (1)
Lipoprotein and Hemocoagulatory Parameters during Therapeutic Plasmapheresis in Homozygous and Heterozygous Familial Hypercholesterolemia (1993) (1)
Neuronal Oxidative Stress is a Common Feature of Alzheimer’s and Parkinson’s Diseases (1998) (1)
Simultaneous Onset of Alzheimer’s Disease in a Husband and Wife in Their Mid-Fifties: What Do We Really Know About Environmental Factors? (2015) (1)
Chapter 8 – Tau Proteins (2017) (1)
Ultrastructural Features of Human Platelets Treated in Vitro with Aggregative and Antiaggregative Prostaglandins. A Freeze-Etching Study (1983) (1)
PO13-357 THE PRIMARY PATHOGENETIC ROLE OF VASCULAR HYPOPERFUSION, AND OXIDATIVE STRESS IN ALZHEIMER DISEASE (2007) (1)
DOES THE OXIDATIVE STRESS AND CEREBRAL ATHEROSCLEROSIS INITIATE BRAIN HYPOPERFUSION AND THE DEVELOPMENT OF ALZHEIMER DISEASE (2008) (1)
Reduction of pinocytotic vesicle surface density in cultured bovine aortic endothelial cells. A quantitative ultrastructural freeze-etching study. (1988) (1)
PICK BODY STRAIGHT FILAMENTS COHTAIK HEUROFILAMENT AND MICROTUBULE ELEMENTS (1986) (1)
Ultrastructural Features of BAEC Studied by Freeze-Etching technique (1981) (1)
B-Mode Imaging and Histomorphometric Evaluation of Carotid Atherosclerosis (1990) (1)
Launch of ‘Atlas Journal of Medical and Biological Sciences’ (2011) (1)
American Dementia: Brain Health in an Unhealthy Society by Daniel R. George and Peter J. Whitehouse Johns Hopkins Press, 2021, 390 pp. (2021) (1)
Minima of eclipsing binary stars (2014) (1)
Abnormal mitochondrial dynamics in Alzheimer disease (2008) (1)
Conformation- and phosphorylation-dependent electron tunnelling across self-assembled monolayers of tau peptides. (2021) (1)
P3-275 Phosphorylation dependent control of oxidative modification in Alzheimer disease (2004) (1)
Role of ferroptosis iron‐dependent cell death in neurodegenerative processes (2021) (1)
Mass Dimension Evaluation of the Optic Nerve Head Micro Vascularity in Non-Glaucomatous Optic Neuropathies (2016) (1)
Nova in the Large Magellanic Cloud 2009 (2009) (1)
Nutrients and Food Constituents in Cognitive Decline and Neurodegenerative Disease (2013) (1)
Natural Gas Powered Heavy Duty Truck Demonstration (1996) (1)
Thursday Oral Session (2009) (1)
Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex (2018) (1)
Unveiling "the switch" from aging to Alzheimer's disease with the senescence-accelerated mouse model (SAMP8) (2011) (1)
Journal of Bioequivalence & Bioavailability (2009) (1)
Ferric Iron Brain Deposition as the Cause, Source and Originator ofChronic Neurodegenerative Diseases (2015) (1)
Antioxidant reversal of oxidative stress-induced memory deficits (1999) (1)
Competitive regulation of aβredox activity by copper and zinc: Parallels in the pathogenetic mechanisms of Alzheimer's disease and familial amyotrophic lateral sclerosis (2000) (1)
Microprocessor dual-fuel diesel engine control system (1986) (1)
London in the Sixties (2002) (1)
Ethics review as a catalyst for progress. (2014) (1)
MSDC-0160 and MSDC-0602 Binding with Human Mitochondrial Pyruvate Carrier (MPC) 1 and 2 Heterodimer (2021) (1)
Food Antioxidants and Alzheimer’s Disease (2009) (1)
NEUROFILAMENT HEAVY SUBUNIT (NFH) IS A SPECIFIC TARGET OF OXIDATIVE DAMAGE IN THE AXON (1998) (1)
Brain Composition: Age-Related Changes (2009) (1)
Promise from the Sea (2016) (1)
P2-003 Cholesterol feeding enhances cerebral amyloid beta pathology in beagles (2004) (1)
A STUDY OF ACTIN BINDING PROTEINS IN HIRANO BODIES (1986) (1)
INTERACTION OF τ WITH AMYLOID ß DEPOSITS (1993) (1)
AWARD LECTURE (REVIEW) Neuropathologic Changes Provide Insights into Key Mechanisms Related to Alzheimer Disease and Related Dementia (2022) (1)
Paired helical filaments from Alzheimer disease patients contain cytoskeletal components (1987) (1)
Parallels Between Major Depressive Disorder and Alzheimer’s Disease: Role of Oxidative Stress and Genetic Vulnerability (2014) (1)
SEQUESTRATION OF IRON BY LEWY BODIES IN PARKINSON DISEASE (1999) (1)
Deep Learning for Alzheimer's Disease Drug Repurposing using Knowledge Graph and Multi-level Evidence (2021) (1)
Amyloid-Vaccination : Testing the Amyloid Hypothesis ? (2006) (1)
Rapid Communication I8 Protein Immunoreactivity IsFoundin theMajority ofNeurofibrillary Tangles of Alzheimer's Disease (1992) (1)
Clinical biomarkers for cancer recognition and prevention: A novel approach with optical measurements. (2018) (1)
Rapid method towards proteomic analysis of dried blood spots by MALDI mass spectrometry (2019) (1)
Dangers of the amyloid-beta vaccination. (2002) (1)
Fractal analysis of lymphocytic nuclear membrane and chromatin in mycosis fungoides and chronic dermatitis (1998) (1)
Nanoparticle-iron Chelator Conjugates as Multifunctional Disease-modifying Drugs for Prevention and Treatment of Alzheimer’s Disease (2012) (1)
Faculty of 1000 evaluation for Prediction of aggregation-prone regions in structured proteins. (2008) (1)
CELL BIOLOGY OF NEURONS IN ALZHEIMER AND OTHER DEGENERATIVE DISEASES (1988) (1)
Involvement of Complex Carbohydrate Chemistry in Alzheimer’s Disease (2005) (1)
Lester (Skip) Binder (1949-2013): in the beginning was tau. (2014) (0)
Looking at Alzheimer‘s disease from a different angle (2014) (0)
Subject Index Vol. 94, 2008 (2008) (0)
P4-185: Mitochondrial dysfunction in Alzheimer's disease (2008) (0)
Faculty Opinions recommendation of The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivo. (2005) (0)
Islet amyloid polypeptide (iapp) (2014) (0)
Reanimating basal forebrain cholinergic neurons in electrophysiology biosimulations using COPASI software (2012) (0)
Short Communication f3PP and Tau Interaction A Possible Link between Amyloid and Neurofibrillary Tangles in Alzheimer's Disease (2007) (0)
P1-388 Failure of cytoplasmic-nuclear transport in Alzheimer’s disease (2006) (0)
Neuroprotective effects of hypoxic preconditioning on streptozotocin-induced animal model of sporadic Alzheimer's disease (2011) (0)
Alzheimer's Disease: Foreword (2004) (0)
Flux and metabolite pathway mapping in the aging and Alzheimer's disease hippocampus (2013) (0)
Lessons from antiamyloid-β immunotherapies in Alzheimer's disease. (2023) (0)
Nonestrogen-based hormonal therapies for Alzheimer’s disease (2008) (0)
Diana a Celebration (1982) (0)
Temporal Primacy of Oxidative Stress in the Pathological Cascade of Alzheimer Disease (2005) (0)
Dissociated Aβ antibody level in newly diagnosed Alzheimer's disease: A population-based study (2009) (0)
Erratum: Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities (Brain Research, 593: 299-303 (1992)) (1993) (0)
P3-372 Oxidative stress and prion protein mutations (2006) (0)
P3-375 Lipoic acid and N-acetyl cysteine protect against mitochondrial-related oxidative stress in fibroblasts from Alzheimer disease patients (2006) (0)
Faculty Opinions recommendation of The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. (2008) (0)
519 Accumulation of segmental abnormal filaments in neuronal processes of Alzheimer disease (1996) (0)
The Changing landscape of Alzheimer’s disease: From Insoluble to Soluble and from Pathogen to Protector (2006) (0)
disease:The roleofamyloid-f3and tau (2006) (0)
Methemoglobin catabolism and Alzheimer's disease (2013) (0)
ABNORMAL PHOSPHORYLATION OF NEUROFILAMENTS FOLLOWING ADMINISTRATION OF ANTIMITOTIC DRUGS: 141 (1987) (0)
OXIDATIVE DAMAGE TO CYTOPLASMIC DNA AND RNA IN SUBSTANTIA NIGRA NEURONS OF PATIENTS WITH PARKINSONʼS DISEASE (1999) (0)
EVIDENCE FOR OXIDATIVE STRESS IN PICKʼS DISEASE AND CORTICOBASAL DEGENERATION: 193 (1995) (0)
Mouse and Human Tau Expression in Different Brain Areas (2022) (0)
PREFRONTAL CORTEX TRANSCRIPTOME BY MULTIPLE RNA-SEQUENCING (2013) (0)
P2-011 A BIOENERGETIC TRAJECTORY OF FEMALE BRAIN AGING AND ALZHEIMER’S DISEASE 1: IMPLICATIONS FOR RISK PREVENTION AND TREATMENT (2013) (0)
Contents Vol. 4, 2006–2007 (2008) (0)
P1-286 Glycogen synthase kinase-3β activity is regulated by products of lipid peroxidation: relevance to Alzheimer disease (2004) (0)
Nutritional Antioxidants, Vitamins, Cognition, and Neurodegenerative Disease (2004) (0)
Book Review:Neurodegeneration Methods and Protocols Jean Harry, Hugh A. Tilson (1999) (0)
Faculty Opinions recommendation of Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1. (2004) (0)
Decline in mitochondrial bioenergetics underlies central insulin resistance in streptozocin-induced model of sporadic Alzheimer's disease (2011) (0)
Natural Product Co-Metabolism and the Microbiota–Gut–Brain Axis in Age-Related Diseases (2022) (0)
Oxidative Stress in Alzheimer Disease: The Earliest Cytological and Biochemical Feature (2004) (0)
Professional Grant Writers [2] (multiple letters) (2004) (0)
An In Vitro Model to Demonstrate Interactions of Neurons, Astrocytes, and Microglia with Alzheimer Senile Plaque Cores: 1 (1995) (0)
P3-306 Differential expression of metabotrophic glutamate receptors (MGlurs) in Alzheimer disease (2004) (0)
Cerebral hemorrhage and amytoid-β [3] (2003) (0)
Oxidative Damage is Correlated with Mitochondrial Autophagy (2015) (0)
Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis (2023) (0)
Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing (2022) (0)
Antibody‐Antigen Dissociation: A Novel Diagnostic Tool in Alzheimer Disease (2008) (0)
P4-162: LRRK2 in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies (2006) (0)
An Epidemiological Approach to the Study of Alzheimer’s Disease (2014) (0)
EXPERIMENTAL INDUCTION OF NEURONAL INCLUSIONS: 123 (1989) (0)
Mark Smith: Pioneer of Alzheimer Disease Research (2012) (0)
Introduction: Imaging in Alzheimer's disease (2005) (0)
Oxidative Adaptation in Aging and Alzheimer’s Disease: The Roles of Amyloid and Tau (2005) (0)
Mark A. Smith: Scholar and Innovator (2011) (0)
Mark Smith: Pioneer of Alzheimer Disease Research (2012) (0)
Molecular Aspects of Neurodegenerative Disease (2003) (0)
DORSAL ROOT GANGLIA IN ALCOHOLIC RATS: TAU AND UBIQUITIN IMMUNOREAC-TIVITY (1990) (0)
Association of mitochondrial signaling in Alzheimer's disease and hypoxia (2011) (0)
Symposium (2004) (0)
INVITED ARTICLE FROM THE 2020 TEXAS ACADEMY OF SCIENCE TEXAS DISTINGUISHED SCIENTIST (2020) (0)
Alzheimer's Disease: Pathology and Pathogenesis (2014) (0)
LRRK2 Directly Interacts with DLP1 to Regulate Mitochondrial Dynamics and Function (2012) (0)
The primary pathogenetic role of vascular contains vasoactive substances, hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease (2005) (0)
Corrigendum to “Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease” (2021) (0)
Alcohol, Cannabis and Combined Metabolites Differentially Affect Peripheral Blood Mononuclear Cell Gene Expression in a Dose-dependent Manner (2023) (0)
P4-166: Overexpression of amyloid precursor protein causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins (2008) (0)
VASCULAR HYPOPERFUSION AND MITOCHONDRIA ABNORMALITY INDUCE OXIDATIVE STRESS THAT APPEARED TO BE A KEY FACTOR FOR THE DEVELOPMENT OF ALZHEIMER DISEASE (2004) (0)
Neurodegenerative Disease and Treatments (2003) (0)
Metal Ions and Neurodegenerative Diseases Paolo Zatta, Editor. World Scientific Publishing Co. Pte. Ltd, Singapore, 2004, pp 400 (2004) (0)
Testing the two-hit hypothesis of Alzheimer disease: Cell cycle re-entry (2013) (0)
Faculty Opinions recommendation of Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. (2004) (0)
TWO NEUROFILAMENT PROBES REACT WITH ALZHEIMER PAIRED HELICAL FILAMENTS AND NOT WITH TAU PROTEINS: 133 (1987) (0)
Neuronal apoptosis - ISN satellite symposium (1999) (0)
SEGMENTAL ACCUMULATION OF ABNORMAL FILAMENTS IN NEURONAL PROCESSES OF ALZHEIMER DISEASE (1996) (0)
Molecular mapping of Alzheimer’s disease: Imaging mass spectrometry (2015) (0)
Mitochondrial Fragmentation Mediates MPP+ Toxicity in Neurons: Implications for Parkinson's Disease (2011) (0)
Neurogenesis in Alzheimer’s Disease (2006) (0)
MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill? (2022) (0)
Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis (2015) (0)
Increased oxidative stress involving olfactory neurons in Alzheimer disease (2000) (0)
Cell Cycle Activation and the Amyloid-β Protein in Alzheimer’s Disease (2006) (0)
Mitochondria Dynamics Abnormalities in Alzheimer Disease (2009) (0)
Faculty Opinions recommendation of Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry. (2007) (0)
Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes. (2023) (0)
Leave the good amyloid β alone [3] (2004) (0)
Mark A. Smith, PhD: Renegade Scientist and Visionary (2011) (0)
Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain (2023) (0)
P1-351: A novel approach to diagnosis: Antigen-antibody disassociation in Alzheimer's disease (2008) (0)
Faculty Opinions recommendation of S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. (2008) (0)
Book review (2007) (0)
Author response for "Role of antioxidants and a nutrient rich diet in Alzheimer's disease" (2020) (0)
Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (2022) (0)
The concept of redox balance in Alzheimer's disease: Mark Anthony Smith 1965–2010 (2011) (0)
ALDEHYDE-MODIFICATION OF THE NEUROFILAMENT COMPONENT OF NEUROFIBRILLARY TANGLES IN ALZHEIMER DISEASE (1993) (0)
Faculty Opinions recommendation of Anchorless prion protein results in infectious amyloid disease without clinical scrapie. (2005) (0)
DIFFERENT STRESS CONDITIONS IN CULTURED NERVOUS TISSUE: RESPONSE OF HEAT‐SHOCK PROTEINS AND UBIQUITIN SYSTEM (1988) (0)
Faculty Opinions recommendation of Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1. (2008) (0)
Mitochondrial autophagocytosis in Alzheimer disease: 126.6 (2007) (0)
Mark A. Smith: neurocytochemistry innovator. (2012) (0)
Immunocytochemical Evidence that the B-Protein Precursor is an Integral Component of Neurofibrillary Tangles of Alzheimer's Disease (2020) (0)
ALZHEIMER DISEASE IS MARKED BY A MAJOR SHIFT IN REDOX BALANCE (1999) (0)
Faculty Opinions recommendation of Microtubule destruction induces tau liberation and its subsequent phosphorylation. (2010) (0)
Faculty Opinions recommendation of Heme binding induces dimerization and nitration of truncated β-amyloid peptide Aβ16 under oxidative stress. (2013) (0)
Sir Martin Roth – A Debt of Gratitude (2007) (0)
Birth of JAD: 20 Years Later (2018) (0)
Oral Presentations OP01: Neurodegenerative Diseases (2008) (0)
Retinal neurodegeneration in euglycemic hyperinsulinemia, prediabetes, and diabetes. (2022) (0)
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances (2020) (0)
Faculty Opinions recommendation of Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ. (2010) (0)
P1-417 Ectopic localization of phospho-Smad2 in the vulnerable neurons of Alzheimer’s disease (2006) (0)
Therapeutic opportunities in Alzheimer disease: Current concepts (2009) (0)
Commentary Do Neurons Have a Choice in Death (2001) (0)
Immunohistochemical detection of increased facilitative glucose transporter-1 expression in corneal endothelial stress (1996) (0)
Chapter 19:Targeting Oxidative Mechanisms in Alzheimer Disease (2010) (0)
Amyloid precursor protein in cell cultures: a 130 kDa polypeptide. (1989) (0)
Alzheimer research forum discussion: Gain or loss of function - Time to shake up assumptions on γ-secretase in Alzheimer disease? Commentary (2007) (0)
Synergy between depression and Alzheimer's disease: A spectrum model of genomic vulnerability with therapeutic (2015) (0)
A New Outlook for Alzheimer’s Disease (2014) (0)
Alzheimer research forum discussion: Gain or loss of function - Time to shake up assumptions on γ-secretase in Alzheimer disease? Commentary (2007) (0)
Faculty Opinions recommendation of The amyloid cascade hypothesis. (2008) (0)
Preface: Alzheimer’s Disease: New Beginnings (2018) (0)
Faculty Opinions recommendation of Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein. (2008) (0)
Amyloid- _ and _ in Alzheimer’s Disease: What is the Neuropathology Trying to Tell Us? (2005) (0)
Faculty Opinions recommendation of Mild cognitive impairment as a diagnostic entity. (2004) (0)
Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass (2014) (0)
Faculty Opinions recommendation of Amyloid precursor protein expression is upregulated in adipocytes in obesity. (2008) (0)
RNA Oxidation in Neurodegenerative Diseases: Sublethal Damage as a Mechanism for Chronic Degeneration (2008) (0)
Mitochondria at the origin of oxidative stress in Alzheimer?s disease (2013) (0)
Is oxidative stress an initiator of mitochondrial failure and vascular hypoperfusion during aging and Alzheimer disease? Present and future (2009) (0)
Oxidative Damage to Axonal Cytoskeletal Proteins (1997) (0)
Microscopic Evaluation of Oxidative Damage in Alzheimer Disease (1997) (0)
Microbialites on Mars: a fractal analysis of the Athena's microscopic images (2015) (0)
Platelets in atherogenesis (1987) (0)
P1-369 Evidence of gonadotropin-induced steroidogenesis in Alzheimer’s disease (2006) (0)
AD6 (8-chorocarbochromen) induces in human circulating platelets ultrastructural modifications that are linked to a reduced platelet activation (1986) (0)
Functional study in the young rTg4510 mouse model of tauopathy (2021) (0)
Quantitative morphometric electron microscopy of platelets (1984) (0)
Life on Mars? Viking Data Reanalysis (2010) (0)
Effects of Quinapril on the development and course of vascular hypertrophy in SHRs (1993) (0)
The primary pathogenetic role of vascular hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease (2008) (0)
Platelet Activation in Hypercholesterolemic Patients Submitted to Therapeutic Plasmapheresis. An Ultrastructural Study. (1997) (0)
Pathobiological determinants of atherosclerosis in youth (PBDAY WHO-ISFC) study: lipid and raised lesions distribution in aortas of young people (1994) (0)
Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (2022) (0)
STRIATED LINEAR NEURITES: A SUBPOPULATION OF CORTICAL NEUROPIL THREADS IN AGING AND ALZHEIMER DISEASE (1993) (0)
Challenges Accepted Approaches to Research in Senile Dementia ( Alzheimer ’ s Disease ) (2011) (0)
Fractal dimension of lymphocytic nuclear membrane in inflammatory and neoplastic infiltrates of the skin (1996) (0)
The WHO-ISCF Study on Atherosclerosis in Youth (PBDAY): A First Morphometric Approach to Aortic Lesions (1989) (0)
On the delayed experimental atherosclerotic involvement of cerebral arteries in monkeys, in rabbits and in spontaneous hypertensive rats (SHR) (1986) (0)
Immunocytochemical Evidence That the ( 3-Protein Precursor Is an Integral Component of Neurofibrillary Tangles of Alzheimer ' s Disease (2014) (0)
O2-04-07 Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1 associated regulator of cyclin B, in Alzheimer disease (2004) (0)
Ultrastructural aspects of platelets in atherosclerosis and related diseases (1986) (0)
Ultrastructural aspects of circulating platelets during experimental atherogenesis and in human hyperlipoproteinemia (1976) (0)
Ultrastructural features of protein secretion from intact platelets. A freeze-etching and ultra-thin section study (1983) (0)
Atherosclerosis and aging: a morphometric study on arterial lesion of elderly and very elderly (ultranonagenarian) necropsy patients (1988) (0)
Faculty Opinions recommendation of The potential role of tau protein O-glycosylation in Alzheimer's disease. (2005) (0)
Faculty Opinions recommendation of Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease. (2008) (0)
Molecular evolution of informational polymers: nonlinear analysis of Bacteria, Archaea and Eukarya RNAs (2009) (0)
Using biology to untie the Gordian knot of Alzheimer's disease (2011) (0)
O4-02-08 Mitochondrial autophagocytosis in Alzheimer disease (2006) (0)
Atherosclerosis in Geriatric Patients (1989) (0)
64 Pulse Oximetry Signals: Chaotic Analysis in The Evaluation of Neonatal Illness Severity (2004) (0)
CloningÃ¢ÂÂs Promise (2013) (0)
WHO-ISFC PBDAY study, II. Topography of atherosclerotic lesions in the right coronary artery in young people (1994) (0)
SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders. (2021) (0)
[Behavior of nucleotides in the liver of the rat after castration and treatment with testosterone]. (1988) (0)
[Morphology of human thrombocytes in freeze-etching technic]. (1981) (0)
Fractal analysis: a powerful tool to perform differential diagnosis and prognosis in cancer and other malignancies (2014) (0)
Entropy Evaluation of Bone Marrow Biopsies in Myelodysplastic Syndromes (2016) (0)
GROWTH STIMULATING EFFECT IN VITRO OF GLYCOSAMINOGLYCANS AND HEPARIN ON BOVINE AORTIC ENDOTHELIAL CELLS (BAEC) (1989) (0)
PHAGOCYTIC PROPERTIES OF ENDOTHELIAL CELLS TOWARDS PLATELETS AND MAST CELLS. (1994) (0)
Thinking Outside the Box in Alzheimer Disease Treatment (2011) (0)
ADF/cofilin-actin rods and synaptic loss in Alzheimer's disease (2010) (0)
Nova Trianguli Australis 2008 (2009) (0)
The amyloid-β pathway in Alzheimer's disease: a plain language summary. (2023) (0)
Modifications of the Freeze-Cleaved Circulating Platelets Membrane in Hypercholesterolemic Rabbits, Prevented by AD6. (1979) (0)
Ultrastructural modifications of circulating platelets in atherosclerosis (1984) (0)
Abstracts of the XVIIth International Congress of Neuropathology (ICN 2010). Salzburg, Austria. September 11-15, 2010. (2010) (0)
General findings regarding atherosclerotic lesions extent and type in the different populations including risk factors (1997) (0)
Basis and Argument into the Work "Parallels on Depression and Alzheimer's Disease and Different Genomic Vulnerability Leading to Therapeutic Utilities" (2015) (0)
WHO-ISFC PBDAY Study. Lipid raised lesion distribution in the right coronary artery and the aortas of young people (1996) (0)
Quantitative ultrastructural study of platelet plasma-membrane in hypercholesterolemic type IIa patients after plasma exchange and LDL-apheresis. (1988) (0)
Faculty Opinions recommendation of Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice. (2008) (0)
Mononuclear cell-vascular endothelial cell interactions: morphometrical and functional in vitro study (1995) (0)
[Effects of high density lipoproteins (HDL) and low density lipoproteins (LDL) on cultured bovine aorta endothelial cells. Preliminary observations on ultrastructural morphology of the plasma membrane by freeze-fracturing]. (1982) (0)
Some ultrastructural and functional observations on platelets of WHHL rabbits". Biology of the arterial wall (1988) (0)
Multifractal Analysis of Muscular Tissue Cryofixed in a Cryostat Chamber (2015) (0)
Lipid lesion distribution in right coronary artery of young people of different countries (PBDAY-WHO-ISFC Study) (1992) (0)
A phase transition of vascular network architecture in human pathologies (2008) (0)
[Studies with the freeze etching method on circulating blood platelets in patients with dyslipemia and in experimental hypercholesteremia. Preliminary note]. (1976) (0)
NR Trianguli Australis (2008) (0)
Complexity analysis of gravitational waves (2021) (0)
Morphological aspects of endothelial cell-monocyte interactions in culture. (1995) (0)
Histomorphometric data on progression with age of atherosclerotic lesions in aorta of WHHL rabbits (1988) (0)
Morphometrical studies of the artery wall hypertrophy in spontaneously hypertensive rats. Effects of Quinapril (1993) (0)
The WHO-ISFC study on pathobiological determinants of atherosclerosis in youth (PBDAY): a first morphometric approach to aortic lesions (1990) (0)
1 : Imaging the Alzheimer Brain : The Pathology and Pathophysiological Bases of Alzheimer ’ s Disease : Implications for Advancing Diagnostic Imaging (2011) (0)
Fractal Analysis in Neuro-ophthalmology (2016) (0)
Molecular evolution in the primitive Earth: nonlinear analysis of archaea tRNAs compared to computer-generated random sequences (2009) (0)
Lipid peroxidation markers are associated with granulovacuolar degeneration but not lipofuscin formation (2010) (0)
Nova in the Large Magellanic Cloud 2009 - Circolare Internazionale IAUC# 9024 (2009) (0)
Alzheimer's disease therapy: a moving target (2011) (0)
Probability-of-occurrence maps of lipid and raised lesions in aortas of young people of different geographical origin (WHO-ISFC PBDAY Study) (1992) (0)
Predatory Practices Are Increasing Among Some Open Access Medical and Biological Journals (2016) (0)
Alzheimer’s and Consciousness: How Much Subjectivity Is Objective? (2021) (0)
Metal Homeostasis and Its Relation to Oxidative Stress in Alzheimer’s Disease (2003) (0)
Origin(s) of life in the primitive Earth and Chaos Science. Probability of spontaneous emergenging of a biosphere (2001) (0)
Life on Mars: time to start (2015) (0)
Susceptibility Differences in Atherosclerotic Involvement of Different Arterial Districts in WHHL Rabbits (1989) (0)
Mark A. Smith: Impresario of Alzheimer (2011) (0)
Image Processing by 16-BIT Personal Computer. Validation Test in a Study of Aortic Sudanophilia in Dietetically Hypercholesterolemic Rabbits (1989) (0)
ACTIVATION OF FERROPTOSIS, AN IRON-DEPENDENT FORM OF NON-APOPTOTIC DEATH IN NEURONS (2019) (0)
Minima of eclipsing binaries and new ephemerides for GSC 03881-00579 and EZ Lacertae (2012) (0)
In vitro effects of heparin and glycosaminoglycans (GAGs) on bovine aortic endothelial cells (BAEC) (1991) (0)
Informational Polymers in the Primitive Earth: Lempel-ZivComplexity and Entropy of tRNAs in Anaerobic Archea Comparedto Computer-Generated Random Data (2015) (0)
[Morphometric analysis of the liver of rats, castrated and treated with testosterone]. (1988) (0)
When the Viking Missions Discovered Life on the Red Planet (2012) (0)
Welcome to the inaugural issue of Fractal Geometry and Nonlinear Analysis in Medicine and Biology (FGNAMB)_ We invite your participation (Editorial) (2015) (0)
Molecular Evolution in the primitive Earth: Fractal dimension of ARCHAEA tRNAs compared to Computer-Generated Random Sequences (2002) (0)
RTN1 and RTN3 protein are differentially associated with senile plaques in Alzheimer’s brains (2017) (0)
Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer’s disease brains (2021) (0)
Ultrasonographic and Histomorphometric Evaluation of Endarterectomy Samples from Carotid Lesions: New Perspectives in Qualitative Evaluation of B-Mode Ultrasound Images (1991) (0)
Postnatal neuronal Bace1 deletion impairs neuroblast and oligodendrocyte maturation. (2022) (0)
Vita in Meridiani Planum, Marte (2015) (0)
Mars Exploration Rover’s image analysis: Evidence of Microbialites on Mars (2015) (0)
Blue Ridge Community and Technical College Board of Governors Meeting (2013) (0)
Meet our associate editor (2016) (0)
Meet the Editorial Board (2015) (0)
[Ultrastructural aspects of human platelet plasma membrane stimulated in vitro with low doses of thrombin during secretion of specific proteins. A freeze fracturing study. Preliminary note]. (1982) (0)
A Beautiful Folly (1994) (0)
Preface (2018) (0)
The Histochemical Society Annual Meeting (1996) (0)
Nutritional supplements and dementia. (2017) (0)
Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (2019) (0)
Oceanography: Not Just the Oceans (2013) (0)
Optogenetics: implications for Alzheimer’s disease research and therapy (2022) (0)
Advances in Biotechnology and Bioscience (2019) (0)
Alzheimer's Disease: Not Just for the Aged? (2023) (0)
The Histochemical Society Annual Meeting (1997) (0)
Editorial Board (2011) (0)
Meet Our Co-Editor (2017) (0)
Meet Our Associate Editor (2018) (0)
Meet our editor (2017) (0)
Editors & Editorial board (2018) (0)
Management of Neuro Degenerative Diseases of Elderly Adults (2016) (0)
Larry Sparks: Innovator and Iconoclast (2013) (0)
Occupational Security and Retraining: How Nova Scotia Youth View Their Future. (1998) (0)
Life on Mars: Clues, Evidence or Proof? (2021) (0)
Two hundred treasured issues! (2015) (0)
On the origin of informational polymers: Nonlinear analysis of bacteria and archaea tRNAs compared to computer-generated random sequences (2008) (0)
Preface. (2018) (0)
Karisma 1959-1960 (1960) (0)
Academic Journals Plagued by Bogus Impact Factors (2017) (0)
The biologic experiments on Mars by Viking Landers and presumptive fossils on the martian meteorite ALH84001 (2001) (0)
A brief guide to the science and art of writing manuscripts in biomedicine (2020) (0)
Morphometric analysis of cryofixed muscular tissue for intraoperative consultation (2016) (0)
Correction to: Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders (2018) (0)
Review of "Why Is Heparin, Despite Being an Anticoagulant, Rarely Associated with Blood Clotting? A Systematic Review" (2021) (0)
Novelty Rate: A Metric for Evaluation of Journals’ Novelty (2015) (0)
Ion-catalyzed reactive oxygen species in sporadic models of parkinson’s disease (2016) (0)
Astrobiological Significance of Sulphur-reducing Microorganisms (2008) (0)
Modifications of the freeze-cleaved circulating platelets in hypercholesterolemic rabbits (45 days) and treated with AD6 (1979) (0)
Microvascular modifications in Rett Syndrome (2015) (0)
First evidence to show the presence of left handed Z-DNA in hippocampus region of brain effected by Alzheimer's Disease (2000) (0)
PBDAY. Steering Committee Meeting. Final Draft Reports. Report from the Siena Reference Centre. (1995) (0)
VBEC: Very busy endothelial cell (1994) (0)
Disordered oral vascular networks in bronchopulmonary dysplasia (2003) (0)
Reduced platelet specific proteins discharge by platelet phosphodiesterase inhibitors (8 Chlorocarbochromen, Carbochromen) (1982) (0)
Ultrastructural modifications of platelet plasma-membrane in vascular disease patients and the effect of a carbochromen derivative (1986) (0)
Spreading of a colon adenoma: a case report (2016) (0)
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation (1997) (0)
Ultrastructural aspects of endothelial cell-monocyte interactions in culture (1992) (0)
Fractal dimension analysis in light and ultrastructural microscopy (1997) (0)
Morphological characteristics of erythrocytes in scanning electron microscopy before and after LDL apheresis for familial hypercholesterolemia (1990) (0)
Ultrastructural and ultrahistochemical observations on bovine cerebral arteries endothelial cells (BCAECs) in primary cultures (1986) (0)
Polyphenols with Anti-Inflammatory Properties: Synthesis and Biological Activity of Novel Curcumin Derivatives (2023) (0)
Vita in Meridiani Planum, Marte;Vita in Meridiani Planum, Marte;Life in Meridiani Planum. Mars. (2015) (0)
Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America. (2021) (0)
Psychrophilic bacteria as possible model of life in Mars or Jovian moons: molecular analysis, a proposal (2007) (0)
Rule Britannia: The Victorian world (1974) (0)
"In vitro" interactions of endothelial cells with monocytes and platelets. Ultrastructural observations (1993) (0)
Blood cell activation: new perspectives from ultrastructural morphometry. (1993) (0)
Anti-amyloidogenicactivityofS-allyl-l-cysteineanditsactivity todestabilizeAlzheimer's!-amyloidfibrilsinvitro (2007) (0)
New Variable Stars Discovered by Data Mining Images Taken during Recent Asteroid Photometric Observations. II. Results from July 2015 through December 2016 (2017) (0)
Migration and proliferation of aortic smooth muscle cells and monocyte/macrophages obtained from cholesterol fed and WHHL rabbits (1988) (0)
Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases (2006) (0)
Nonlinear analysis of random walks: a tool to analyze nucleic acid sequences (2015) (0)
Histomorphometric study of the aorta and the coronary arteries in youth from different geographic origins (WHO-ISFC PBDAY STUDY) (1996) (0)
Correspondence re: B.M. Wagner. VBEC: very busy endothelial cell. Mod Pathol 7:2, 1994. (1994) (0)
[On the growth of cultured bovine aortic endothelial cells. Preliminary observations on ultrastructural morphology by freeze-etching and quantitation of growth rate by phase contrast microscopy: effect of glycosaminoglycans]. (1982) (0)
WHO-ISFC PBDAY Study, I. Distribution of lipid and raised atherosclerotic lesions in the aortas of young people (5–34) of various ethnic origins (1994) (0)
Platelets in the platelet-vessel wall interaction. (1985) (0)
Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson’s Disease (2012) (0)
Comparative evaluation of echographic and histomorphometric data of carotid endarterectomy samples (1987) (0)
Life on Icy Worlds (2010) (0)
Ultrastructural morphometry of leukocytes and platelets in familial hypercholesterolemia patients subjected to LDL-apheresis (1997) (0)
Farm animal behaviour (1981) (0)
The great British picture show : from the nineties to the seventies (1975) (0)
The benefits of AC variable frequency drives (1987) (0)
The life of Python : the history of something completely different (1995) (0)
Movies from the mansion: A history of Pinewood Studios (1976) (0)
Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders (2018) (0)
Faculty Opinions recommendation of Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity. (2005) (0)
Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acid (2010) (0)
Alzheimer’s disease: the impact of age-related changes in reproductive hormones (2004) (0)
Preface: Lars Gustafson, Lund; Arne Brun, Lund (1999) (0)
Constructing a neuroethical framework for Alzheimers disease research employing big data (2016) (0)
DLP1‐Dependent Mitochondrial Fragmentation Mediates 1‐methyl‐4‐phenylpyridinium (MPP+) Toxicity in Neurons (2011) (0)
INDUCTION OF NAPH CYTOCHROME P450 REDUCTASE BY AMYLOID β PROTEIN: FRIEND OR FOE OF NEURONS? (1999) (0)
Faculty Opinions recommendation of Interaction of Tau with Fe65 links tau to APP. (2005) (0)
Faculty Opinions recommendation of Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. (2005) (0)
[P2–231]: WITHDRAWN (2017) (0)
Faculty Opinions recommendation of Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease. (2008) (0)
P4-170: Peroxidative nitrotyrosine formation in Alzheimer's disease (2008) (0)
Role of Amyloid-beta in Alzheimer's Disease (2005) (0)
Hydroxynonenal generated crosslinking fluorophores accumulate in Alzheimer's disease (2009) (0)
Asking the right questions [4] (1999) (0)
EVIDENCE FOR WIDESPREAD PEROXYNITRITK-MF.DIATED DAMAGE IN ALZHEIMER DISEASE (1997) (0)
Faculty Opinions recommendation of Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. (2004) (0)
P3-369 Intraneuronal amyloid-β42 may silence oxidative stress in Alzheimer’s disease (2006) (0)
P4-250 Redox-active iron oxidizes ribosomal RNa in neurons vulnerable to Alzheimer's disease (2004) (0)
Disturbance in AMP-activated protein kinase (AMPK) signaling pathway in Alzheimer's disease (2010) (0)
Faculty of 1000 evaluation for Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. (2004) (0)
The β amyloid protein precursor: Analysis of mRNAs in ad and control brains and of soluble derivatives in human cerebrospinal fluid (1990) (0)
Faculty Opinions recommendation of Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria. (2008) (0)
AMYLOID PRECURSOR PROTEIN IN CULTURED HUMAN CELLS (1988) (0)
Journal of Parkinson's Disease – Birth of JAD's New Sister (2011) (0)
Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases (2006) (0)
R-α-lipoic acid as a potent agent of mitochondrial protection in alzheimer’s disease (2012) (0)
Faculty Opinions recommendation of Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS. (2004) (0)
Elongation affinity of A$\beta$-42 via molecular dynamics simulations (2017) (0)
Are Alzheimer's Disease and Aging Evolutionary? (2013) (0)
Faculty Opinions recommendation of Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells. (2005) (0)
Faculty Opinions recommendation of Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. (2005) (0)
Isotyping the human TOMM40 variable-length polymorphism by gene amplification and restriction digest. (2012) (0)
Faculty Opinions recommendation of Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. (2005) (0)
Leptin in alzheimer's disease and other cognitive disorders and its association with underlying lipid abnormalities (2014) (0)
Journal of huntington's disease -The family gets bigger (2012) (0)
Journal of Alzheimer's disease established as a leading journal. (2001) (0)
Editor Note on Mass Spectra for Revealing Disease - Associated Pathways (2016) (0)
The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics (2007) (0)
IS UBIQUITIN AN EARLY MARKER OF NEURITIC DEGENERATION SECONDARY TO AMYLOID DEPOSITION IN BOTH ALZHEIMER AND CREUTZFELDT-JAKOB DISEASES?: 218 (1990) (0)
Senile plaques and neurofibrillary tangles: The concurrent lesions of alzheimer's disease (1995) (0)
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study (2020) (0)
809 A specific marker of oxidative protein modifications, 2,4-dinitrophenylhydrazine, labels the neurofibrillary pathology of Alzheimer disease (1996) (0)
Correction to: Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders (2018) (0)
Glial Cell Extracellular Matrix in Alzheimer's Disease (1995) (0)
Testing the two-hit hypothesis of Alzheimer?s disease: Cell cycle re-entry (2013) (0)
Total antioxidant status in newly diagnosed Alzheimer's patients: Population based study (2010) (0)
P3-229 P130, a regulator of the G1 phase of the cell cycle, in Alzheimer disease: Evidence of a stuttered cell cycle (2006) (0)
Faculty Opinions recommendation of Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. (2004) (0)
Cellular Pathology of Alzheimer Disease (2015) (0)
Contents Vol. 94, 2008 (2008) (0)
Consent: Practical Principles for Clinicians (2011) (0)
Faculty Opinions recommendation of Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. (2004) (0)
Neurodegenerative Phenotypes Induced by MYC‐Driven Neuronal Cell Cycle Re‐entry: Relevance to Alzheimer Disease (2008) (0)
Alzheimer’s Disease: Questions Raised by a Herpes Virus Origin Current Opinions in Neurological Science (2019) (0)
Oxidative stress and neuropsychiatric disorders in the life spectrum (2017) (0)
Oxidative Stress in Aging and Neurodegenerative Diseases: From Biology to Therapy, Perugia, Italy, May 2003 (2004) (0)
AMYLOID PRECURSOR PROTEIN EXPRESSION AND LOCALIZATION IN RAT CEREBRAL CORTEX CULTURES (1993) (0)
Faculty Opinions recommendation of Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. (2005) (0)
Transcriptome-To-Reactome Biosimulation: Oxidative Pathways to Apoptotic Cell Death (2012) (0)
Faculty Opinions recommendation of Deficiency of the copper chaperone for superoxide dismutase increases amyloid-β production. (2010) (0)
Oxidative damage is correlated with mitochondrial autophagy (2015) (0)
Acetylation - - a novel stabilizing posttranslational mechanism in Alzheimers disease (2003) (0)
Faculty Opinions recommendation of Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation. (2008) (0)
Phosphorylation, Microtubule Binding and Aggregation of Tau Protein in Alzheimer's Disease (2002) (0)
Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization (2021) (0)
Faculty Opinions recommendation of Testing the amyloid toxicity hypothesis of Alzheimer's disease in transgenic Caenorhabditis elegans model. (2004) (0)
ADVANCED GLYCATION AND LIPID MODIFICATION OF ROSENTHAL FIBERS IN ALEXANDERʼS DISEASE (1997) (0)
Faculty Opinions recommendation of Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. (2009) (0)
Neuronal apoptosis--ISN satellite symposium. 5-7 August 1999, Tübingen, Germany. (1999) (0)
Mitochondrial Autophagocytosis in Alzheimer Disease (2007) (0)
Faculty Opinions recommendation of Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. (2005) (0)
Upcoming Meetings Related to Alzheimer's Disease. (2008) (0)
O3-04-07 Vascular and metabolic failure in Alzheimer disease (2004) (0)
P4-171: Cerebral hypoperfusion-induced oxidative stress and mitochondrial failure as initiators of aging and Alzheimer's disease pathology (2008) (0)
Symposium S18: Oxidative Stress in Neurodegenerative Diseases (2004) (0)
Molecular Characterization of the ??/??PP Interaction: The Pathogenic Pathway? (1995) (0)
Mark A. Smith, 1965-2010: consummate student of pathogenesis. (2011) (0)
P4-242 Oxidative damage in ferritin-induced neurodegeneration (2004) (0)
Editorial: Oxidative Stress Revisited—Major Role in Vascular Diseases, Volume II (2022) (0)
Alzheimer's plaques re-created in a test tube: Further insights into the mechanism of amyloid plaque formation (2000) (0)
Oxidative Stress Associated Signal Transduction Cascades in Alzheimer Disease (2009) (0)
Author and Subject Index (1998) (0)
Latrepirdine (Dimebon™) modulate mitochondrial dynamics in AD cell models (2010) (0)
Increased Phosphorylation and Mitochondrial Association of Bax in the Brains of Alzheimer's Disease Individuals (2017) (0)
Metals and Mitochondria in Neurodegeneration (2017) (0)
In Memoriam: Mark A. Smith, PhD: Neuroscientist and Visionary (2011) (0)
Chapter 2 Oxidative Stress and Alzheimer ’ s Disease (2017) (0)
Faculty Opinions recommendation of The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. (2004) (0)
Alzheimer's disease: Pathology vs etiology (2007) (0)
Faculty Opinions recommendation of MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. (2005) (0)
Protein Misfolding in Alzheimer's Disease: Pathogenic or Protective? (2007) (0)
P2-001 MELATONIN SUPPLEMENT ONLYAT SPECIFIC TIMING RESCUES THE PATHOLOGYAND MEMORY DEFICITS IN TG2576 MICE VIA TARGETING GSK-3 (2013) (0)
The Importance of Histochemical Detection of Oxidative Damage in Tissue (2010) (0)
Presenilin mutations impair mitochondrial dynamics in neurons (2013) (0)
MUSCLE CELL DEGENERATION OF THE POSTERIOR CEREBRAL ARTERY IN ALZHEIMER DISEASE (1996) (0)
Pathological phenotype in familial neurodegenerative disease: implications for families and therapeutic constructs (2011) (0)
Faculty Opinions recommendation of Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. (2005) (0)
Faculty Opinions recommendation of A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. (2005) (0)
Universal research index: An inclusive metric to quantify scientific research output (2023) (0)
Faculty of 1000 evaluation for Degradation of BACE by the ubiquitin-proteasome pathway. (2004) (0)
Transcriptome-to-reactome biosimulation: Basal forebrain cholinergic neuron neurotrophin signaling (2012) (0)
Faculty Opinions recommendation of Kinetic control of dimer structure formation in amyloid fibrillogenesis. (2004) (0)
Special Report from the Challenging Views of Alzheimer ’ s Disease What is aging ? What is its role in Alzheimer ’ s disease ? What can we do about it ? (2005) (0)
Commentary on “Perspective on a pathogenesis and treatment of Alzheimer’s disease.” Therapeutic strategies for Alzheimer’s disease: The need for a new era of innovation (2006) (0)
Carbonyl-Related Modification of Neurofilaments in Aizheimer Disease: 93 (1995) (0)
Neuropathology in Consecutive Forensic Consultation Cases with a History of Remote Traumatic Brain Injury. (2019) (0)
Medicinal chemistry of neurodegenerative diseases--fourth international symposium. 30 January-2 February 2000, Cancun, Mexico. (2000) (0)
β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification (2020) (0)
α1-CHYMOTRYPSIN AND α1-TRYPSIN IMMUNOLOCALIZE WITH NEUROFIBRILLARY TANGLES AND SENILE PLAQUES OF ALZHEIMER DISEASE (1993) (0)
CEREBELLAR ß/A4 DEPOSITS AND ACUTE PHASE PROTEINS IN ALZHEIMERʼS DISEASE (1993) (0)
Neuronal leptin resistance in Alzheimer's disease (2013) (0)
Is Alzheimers Disease a Myth? When is Disease a Disease? (2009) (0)
Oxidative Damage to RNA in Aging and Neurodegenerative Disorders (2012) (0)
Pharmaceutical Regulation: Crossroad of Opportunity as the Distinction between Food and Drugs Blurs (2012) (0)
FTD and ADHD: Pathology versus pathophysiology (2001) (0)
Neurofibrillary tangles, neuropil threads and neuritic plaques in Alzheimer disease: Are these lesions interrelated (1990) (0)
Beta-amyloid reduces the expression of antioxidant repair genes (2012) (0)
Involvement of gonadotropins in cognitive function: Implications for Alzheimer's disease (2009) (0)

This paper list is powered by the following services:

Other Resources About George Perry

en.wikipedia.org

What Schools Are Affiliated With George Perry ?

George Perry is affiliated with the following schools:

Image Attributions

Image Source for George Perry